[go: up one dir, main page]

FI63596C - MICROBIA DIAGNOSIS FOERFARANDE SOM GRUNDAR SIG PAO SKIKTSHYBRIDISERING AV NUCLEINSYROR OCH VID FOERFARANDET ANVAENDA KOMBINATIONER AV REAGENSER - Google Patents

MICROBIA DIAGNOSIS FOERFARANDE SOM GRUNDAR SIG PAO SKIKTSHYBRIDISERING AV NUCLEINSYROR OCH VID FOERFARANDET ANVAENDA KOMBINATIONER AV REAGENSER Download PDF

Info

Publication number
FI63596C
FI63596C FI813251A FI813251A FI63596C FI 63596 C FI63596 C FI 63596C FI 813251 A FI813251 A FI 813251A FI 813251 A FI813251 A FI 813251A FI 63596 C FI63596 C FI 63596C
Authority
FI
Finland
Prior art keywords
nucleic acid
reagent
fragment
labeled
plasmid
Prior art date
Application number
FI813251A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI63596B (en
Inventor
Tuula Marjut Ranki
Hans Erik Soederlund
Original Assignee
Orion Yhtymae Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Yhtymae Oy filed Critical Orion Yhtymae Oy
Priority to FI813251A priority Critical patent/FI63596C/en
Priority to PCT/FI1982/000038 priority patent/WO1983001459A1/en
Priority to EP82902982A priority patent/EP0098267A1/en
Priority to AU89575/82A priority patent/AU548854B2/en
Priority to JP57502956A priority patent/JPS58501703A/en
Priority to HU823529A priority patent/HU196242B/en
Priority to JP57-502956A priority patent/JPH0632637B2/en
Priority to FI823452A priority patent/FI823452A0/en
Priority to US06/434,182 priority patent/US4486539A/en
Priority to DE8282305489T priority patent/DE3277917D1/en
Priority to DE198282305489T priority patent/DE79139T1/en
Priority to EP82305489A priority patent/EP0079139B1/en
Priority to AT82305489T priority patent/ATE31735T1/en
Priority to CA000413539A priority patent/CA1192120A/en
Publication of FI63596B publication Critical patent/FI63596B/en
Priority to NO83832061A priority patent/NO163699C/en
Priority to DK198302751A priority patent/DK173744B1/en
Application granted granted Critical
Publication of FI63596C publication Critical patent/FI63596C/en
Priority to SU833663405A priority patent/SU1386031A3/en
Priority to RO112563A priority patent/RO86356B/en
Priority to US06/566,532 priority patent/US4563419A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701Specific hybridization probes
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/81Packaged device or kit
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/804Radioisotope, e.g. radioimmunoassay
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/807Apparatus included in process claim, e.g. physical support structures
    • Y10S436/808Automated or kit
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/811Test for named disease, body condition or organ function
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/823Immunogenic carrier or carrier per se

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Toxicology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Sandwich hybridization of nucleic acids can be used for the identification of microorganisms or groups of microorganisms present in a sample. The technique can be used to identify, from a single sample containing nucleic acids of the microorganisms or groups of microorganisms to be identified, after first rendering the said nucleic acids single-stranded, all the microorganisms or groups of microorganisms by adding to the sample a pair of nucleic acid reagents for each microorganism or group of microorganisms to be identified, of which pair one nucleic acid reagent is attached to a solid carrier in the single-stranded form and the other contains a completely different nucleic acid fragment from the same microorganism or group of microorganisms, which fragment is labelled with a marker. The nucleic acid fragments of a pair hybridize to a complementary single-stranded nucleic acid from the sample and the hybrid thus formed on the solid carrier is labelled with the marker. Because the labelled nucleic acid reagent does not hybridize directly with the reagent attached to the solid carrier, only those carriers having attached nucleic acid reagents corresponding to nucleic acids in the sample become labelled and the presence of such carrier-bound labels can be measured using established methods.

Description

6359663596

Nukleiinihappojen kerroshybridisaatioon perustuva mikrobi-diagnostinen menetelmä ja menetelmässä käytettäviä reagenssien yhdistelmiä 5Microbial diagnostic method based on layer hybridization of nucleic acids and combinations of reagents used in the method 5

Keksinnön kohteena on nukleiinihappojen kerroshybridisaatioon kiinteällä kantajalla perustuva mikrobidiagnosti-10 nen menetelmä yhden tai useamman mikrobin ja/tai mikrobi- ryhmän yhtäaikaiseksi osoittamiseksi yhdestä jakamattomasta näytteestä sekä menetelmässä käytettävä sarja reagenssien yhdistelmiä.The invention relates to a microbial diagnostic method based on layered hybridization of nucleic acids on a solid support for the simultaneous detection of one or more microbes and / or microbial groups in a single undivided sample and to a series of reagent combinations used in the method.

15 Perinteisessä mikrobidiagnostiikassa mikrobin läsnäolo tutkittavissa näytteissä on osoitettu eristämällä kyseinen mikrobi. Rikastuskasvatuksen jälkeen mikrobi on tunnistettu joko biokemiallisten ominaisuuksiensa perusteella tai immunologisin menetelmin. Tällainen diagnostiikka 20 edellyttää, että näytteessä oleva mikrobi on lisääntymiskykyinen. Eristämisen kautta tapahtuva tunnistus on lisäksi työläs menetelmä, joka,virusten kyseessä ollen saattaa kestää 4-6 viikkoa.15 In traditional microbial diagnostics, the presence of a microbe in test samples has been demonstrated by isolating the microbe in question. After enrichment culture, the microbe is identified either by its biochemical properties or by immunological methods. Such diagnostics 20 require that the microbe in the sample be reproducible. In addition, detection through isolation is a laborious method which, in the case of viruses, may take 4 to 6 weeks.

25 Keksinnön tarkoituksena on aikaansaada diagnostinen menetelmä, jossa mikrobin läsnäolo näytteessä osoitetaan tunnistamalla sen perintöaines, nukleiinihappo, herkän ja spesifisen nukleiinihappohybridisaation avulla. Nukleiinihappohybridisaatio sinänsä on vanha ja tunnettu 30 menetelmä nukleiinihappojen identiteettiä tutkittaessa. Vastakkaismerkkisillä nukleiinihapposäikeillä on kyky muodostaa tiukka kaks isäikeinen rakenne vastinemästen pariutumissäännön perusteella, ja syntynyt hybridi voidaan erottaa yksisäikeiseksi jääneestä nukleiini-35 haposta.It is an object of the invention to provide a diagnostic method in which the presence of a microbe in a sample is detected by identifying its genome, nucleic acid, by sensitive and specific nucleic acid hybridization. Nucleic acid hybridization per se is an old and known method for studying the identity of nucleic acids. Opposite-branded nucleic acid strands have the ability to form a tight two-stranded structure based on the mating rule of the counterparts, and the resulting hybrid can be distinguished from the single-stranded nucleic acid.

2 635962 63596

Nukleiinihapon tunnistukseen perustuvia menetelmiä on tähän mennessä sovellettu mikrobidiagnostiikkaan jonkin verran. Enterotoksigeeninen E. coli -bakteeri on osoitettu ulostenäytteistä pesäkehybridisaation avulla 5 käyttäen koettimena toksiinin tuotosta vastaavaa geeniä.Methods based on nucleic acid identification have so far been applied to microbial diagnostics to some extent. Enterotoxigenic E. coli has been detected in faecal samples by colony hybridization 5 using the gene responsible for toxin production as a probe.

Positiivinen hybridisaatio havaitaan autoradiografiän avulla (Moseley, S.L. et ai. J. Infect. Dis. (1980) 142, 892 - 898). Pesäkehybridisaatio perustuu alun-10 perin Grunsteinin ja Hognessin kehittämään menetelmään (Proc. Natl. Acad. Sei. USA (1975) 72, 3961 - 3965). Lisäksi hybridisaatiota on sovellettu Herpes simplex 1 ja Herpes simplex 2 -virusten erottamiseen toisistaan (Brautigam A.R. et ai. J. Clin. Microbiol. (1980) 12, 15 226 - 234), ei kuitenkaa pikadiagnostisena menetelmänä vaan rikastekasvatuksen jälkeen virusta tyypitettäessä. Tässä menetelmässä liukoinen kaksisäikeinen hybridi erotetaan yksisäikeiseksi jääneestä affiniteetti-kromatografiän avulla.Positive hybridization is detected by autoradiography (Moseley, S.L. et al. J. Infect. Dis. (1980) 142, 892-898). Colony hybridization is based on the method originally developed by Grunstein and Hogness (Proc. Natl. Acad. Sci. USA (1975) 72, 3961-3965). In addition, hybridization has been applied to distinguish between Herpes simplex 1 and Herpes simplex 2 viruses (Brautigam A.R. et al. J. Clin. Microbiol. (1980) 12, 15226-234), but not as a rapid diagnostic method but after concentrate culture in virus typing. In this method, a soluble double-stranded hybrid is separated from single-stranded hybrid by affinity chromatography.

2020

Hiljattain on tehty työ, jossa Epstein-Barr-viruksella infektoiduista soluista peräisin oleva DNA, ts. näyte, tiettyjen käsittelyjen jälkeen on suoraan kiinnitetty filttereille. Kyseinen nukleiinihappo tunnistetaan 25 hybridisoimalla filtterit radioaktiivisen koettimen läsnäollessa ja positiivinen hybridisaatio detektoidaan autoradiografiän avulla (Brandsma, I. & Miller, K. (1980) Proc. Natl. Acad. Sei. USA 77, 6851 - 6855).Recently, work has been done in which DNA from cells infected with Epstein-Barr virus, i.e., a sample, is directly attached to filters after certain treatments. The nucleic acid in question is identified by hybridizing the filters in the presence of a radioactive probe and positive hybridization is detected by autoradiography (Brandsma, I. & Miller, K. (1980) Proc. Natl. Acad. Sci. USA 77, 6851-6855).

30 Julkaisussa the Lancet 10 Det., ss. 765 - 7, 1982 esitetään samantapainen menetelmä, jossa radioaktiivisesti leimatulla koettimella osoitetaan hepatitis B-virus näytteestä, jonka DNA on saatettu yksisäikeiseksi ja on kiinnitetty nitroselluloosafiltteriin. Hakemusjulkaisussa 35 DE 2950295 kuvataan tällaisen hepatitis B-viruksen radioaktiivisella merkkiaineella varustetun koettimen valmistusmenetelmä yhdistelmä-DNA-tekniikkaa hyväksikäyttäen.30 In the Lancet 10 Det., P. 765-7, 1982 discloses a similar method in which a radiolabeled probe detects hepatitis B virus from a sample whose DNA has been made single-stranded and attached to a nitrocellulose filter. DE 2950295 describes a method for the preparation of such a hepatitis B virus radiolabeled probe using recombinant DNA technology.

3 635963 63596

Keksintömme mukaisessa menetelmässä käytetään sarjaa rea~ genssien yhdistelmiä, jotka koostuvat vähintään kahdesta erilaisesta nukleiinihapporeagenssista, jotka on valmistettu saman mikrobin tai mikrobiryhmän genomin eri osista.The method of our invention uses a series of combinations of reagents consisting of at least two different nucleic acid reagents prepared from different parts of the genome of the same microbe or group of microbes.

5 Näistä nukleiinihapporeagensseista toinen on sidottu kiinteään kantajaan ja toinen on leimattu merkkiaineella.5 Of these nucleic acid reagents, one is bound to a solid support and the other is labeled with a label.

Näiden kahden nukleiinihapporeagenssin avulla voidaan suoraan näytteestä, jonka DNA on saatettu yksisäikeiseksi, osoittaa kaikki mikrobit ja mikrobiryhmät, joita varten 10 on valmistettu reagensseja. Keksintömme mukaisen kahdesta reagenssista koostuvan sarjan käyttö tekee diagnostisoimis-menetelmän huomattavasti spesifisemmäksi kuin edellä kuvattu menetelmä ja mahdollistaa myös erilaisten kitti-yhdistelmien rakentamisen ja samanaikaisen käytön ilman 15 että nämä reagenssit häiritsevät toisiaan ja testin spesifisyyttä .These two nucleic acid reagents can be used to directly detect all microbes and groups of microbes for which reagents have been prepared from a single-stranded DNA sample. The use of a kit of two reagents according to our invention makes the diagnostic method considerably more specific than the method described above and also allows the construction and simultaneous use of different kit combinations without interfering with each other and the specificity of the test.

Käsiteltävänä oleva keksintö perustuu kerroshybridisaa-tiotekniikkaan (Dunn, A.R. & Hassell, 3.A. (1977) Cell 12, 20 23 - 36), jonka ansiosta näytteen käsittely ja hybridin detektio saadaan yksinkertaiseksi. Tämän takia tekniikka soveltuu erinomaisen hyvin diagnostiseen käyttöön.The present invention is based on the layer hybridization technique (Dunn, A.R. & Hassell, 3.A. (1977) Cell 12, 20 23-36), which simplifies sample handling and hybrid detection. For this reason, the technology is excellently suited for diagnostic use.

Keksinnön mukaisessa menetelmässä yhdestä ja samasta 25 näytteestä, joka sisältää diagnostisoitavien mikrobien tai mikrobiryhmien yksisäikeiseksi saatettuja nukleiinihappoja, voidaan sitä jakamatta tunnistaa kaikki halutut mikrobit tai mikrobiryhmät lisäämällä näytteeseen jokaista tunnistettavaksi tarkoitettua mikrobia tai mikrobiryhmää 30 kohden kaksi nukleiinihapporeagenssia. Nämä nukleiini-happoreagenssit sisältävät samasta mikrobista tai 63596 mikrobiryhmästä peräisin olevat keskenään täysin erilaiset mutta edullisesti toistensa lähettyvillä sijainneet nukleiinihappo-fragmentit, jotka voidaan valmistaa joko suoraan mikrobigenomista tai sinänsä tunnettua yhdistelmä-QNA-5 tekniikkaa hyväksi käyttäen ja näistä nukleiinihappo- fragmenteista toinen on saatettu yksisäikeiseksi ja kiinnitetty kiinteään kantajaan edullisesti nitroselluloosa-filtterille ja toinen on saatettu yksisäikeiseksi ja leimattu jollakin menetelmään soveltuvalla merkkiaineella. 10 Kun nämä nukleiinihapporeagenssit, kaksi erilaista jokaista tunnistettavaksi tarkoitettua mikrobia tai mikrobi-ryhmää kohden, saatetaan kosketukseen näytteessä olevien tunnistettavaksi tarkoitettujen yksisäikeisten nukleiinihappojen kanssa, nämä nukleiinihapot sitoutuvat kiinteällä 15 kantajalla oleviin vastaaviin tunnistaviin nukleiinihappo-fragmentteihin ja muodostuneet kiinteällä kantajalla olevat hybridit leimautuvat vastaavien leimattujen nukleiinihappo-fragmenttien avulla. Nämä leimatut nukleiinihappofragmen-tit eivät yksin hybridisoidu kiinteällä kantajalla oleviin 20 nukleiinihappofragmentteihin vaan näytteestä peräisin oleviin yksisäikeisiin nukleiinihappoihin. Tällöin ainoastaan ne kiinteät kantajat, joihin on sitoutunut näytteessä olevia vastaavia nukleiinihappoja, leimautuvat, ja nämä kiinteät kantajat voidaan huuhtoa ja leimaus mitata sinänsä 25 tunnetuin menetelmin.In the method of the invention, all desired microbes or microbial groups can be identified without dividing from one and the same sample containing nucleic acids of single-stranded microbes or microbial groups to be diagnosed by adding two nucleic acid reagents for each microbial or microbial group to be identified. These nucleic acid reagents contain completely different but preferably closely spaced nucleic acid fragments from the same microbe or 63596 microbial clusters, which can be prepared either directly from the microbial genome or by recombinant QNA-5 techniques known per se, and one of these nucleic acid fragments is isolated. and attached to a solid support, preferably a nitrocellulose filter, and the other is monofilamented and labeled with a label suitable for the method. When these nucleic acid reagents, two different for each microbial or group of microbes to be identified, are contacted with the single-stranded nucleic acids to be identified in the sample, these nucleic acids bind to the corresponding nucleic acid fragments on the solid support. fragments. These labeled nucleic acid fragments alone do not hybridize to solid support nucleic acid fragments but to single-stranded nucleic acids from a sample. In this case, only those solid supports to which the corresponding nucleic acids in the sample are bound are labeled, and these solid supports can be rinsed and the labeling measured by methods known per se.

Keksinnön mukaista menetelmää voidaan periaatteessa käyttää kaikkien nukleiinihappoja, joko DNA:ta tai RNA:ta sisältävien organismien kuten esimerkiksi virusten, bakteerien, 30 homeiden ja hiivojen tunnistamiseksi. Tämän menetelmän erityisetuna voidaan pitää sitä, että samasta näytteestä voidaan yhtäaikaisesti tutkia kaikkien kyseeseen tulevien sekä bakteerien että virusten läsnäolo riippumatta siitä sisältävätkö mikrobit DNArta tai RNA:ta. Reagensseja 35 yhdistelemällä voidaan ts. rakentaa "kitti”-kokonaisuuksia siten, että kutakin tunnistettavaa mikrobia varten on oma 5 63596 tunnuksella varustettu kiinteä kantajansa ja merkkiaineella varustettu nukleiinihapporeagenssinsa. Näytteeseen voidaan lisätä kaikki reagenssien yhdistelmään kuuluvat filtterit yhdellä kertaa, samoin leimatut nukleiinihappo-5 reagenssit. Kun hybridisaatio on tapahtunut, kiinteät kantajat pestään ja leimautuminen mitataan. Ainoastaan oikea kiinteä kantaja tulee leimatuksi eli se jota vastaava mikrobigenomi oli näytteessä.The method according to the invention can in principle be used for the identification of all organisms containing nucleic acids, either DNA or RNA, such as, for example, viruses, bacteria, molds and yeasts. A particular advantage of this method is that the same sample can be tested simultaneously for the presence of all relevant bacteria and viruses, regardless of whether the microbes contain DNA or RNA. That is, by combining the reagents 35, "kit" assemblies can be constructed so that each identifiable microbe has its own solid support and labeled nucleic acid reagent with 5,63596. All filters in the reagent combination can be added to the sample at once, as well as labeled nucleic acid reagents. Once hybridization has taken place, the solid supports are washed and labeling is measured, and only the correct solid support is labeled, i.e. the one with the corresponding microbial genome in the sample.

10 Menetelmää ja sarjaa reagenssien yhdistelmiä voidaan käyttää mm. lääketieteellisessä mikrobiologiassa, eläinlääketieteellisessä mikrobiologiassa, elintarvikehygienisissä tutkimuksissa sekä kasvitautien mikrobidiagnostiikassa. Näytteeksi kelpaavat kaikki eläin- tai kasvikudoksesta 15 peräisin olevat homogenaatit, potilaseritteet kuten veri, uloste, nenänielu- ja uretralima. Voidaan arvioida, että menetelmä on riittävän herkkä osoittamaan kliinisissä näytteissä normaalisti esiintyvät mikrobimäärät. Näytteessä olevan mikrobin esirikastus viljelyn avulla on 20 luonnollisesti mahdollista ennen tunnistustestin suorittamista ja joissakin tapauksissa se on suorastaan välttämätöntä. Menetelmä soveltuu myös sellaisten näytteiden tutkimiseen, joista mikrobi ei ole enää viljeltävissä, mutta mikrobin osia on vielä runsaasti näytteessä 25 (esim. antibioottihoito on aloitettu) tai mikrobin viljely on erityisen työläs ja vaikea toimenpide (esim. anaerobiset bakteerit, joita kuitenkin on runsaasti märkänäytteissä, kun kyseessä on anaerobin aiheuttama infektio).10 The method and a series of combinations of reagents can be used e.g. in medical microbiology, veterinary microbiology, food hygiene research and microbial diagnostics of plant diseases. All homogenates from animal or plant tissue, patient secretions such as blood, faeces, nasopharynx and urethral mucus are suitable as samples. It can be estimated that the method is sensitive enough to detect microbial counts normally present in clinical specimens. Pre-enrichment of the microbe in the sample by culture is, of course, possible before performing the identification test and in some cases it is absolutely necessary. The method is also suitable for examining samples from which the microbe is no longer cultured but the microbial constituents are still abundant in the sample (eg antibiotic treatment has been started) or microbial culture is a particularly laborious and difficult procedure (eg anaerobic bacteria abundant in wet samples). in the case of anaerobic infection).

3030

Menetelmää voidaan soveltaa kliinisen lääketieteen ja elintarvikehygienian mikrobidiagnostiikassa esim. seu-raavien mikrobien tai mikrobiryhmien tunnistamiseen.The method can be applied in microbial diagnostics of clinical medicine and food hygiene, e.g. to the identification of the following microbes or groups of microbes.

66

Respiratoriset infektiot: 63596 a) Bakteerit: ^-hemolyyttinen streptococci, (A-ryhmä), Haemophilus influenzae. Pneumococci, Mycoplasma 5 pneumoniae, mykobakteerit b) Virukset: Influenza A, Influenza B, Parainfluenssa 1-3, Respiratory syncytial virus, adenovirukset, coronavirukset, rhinovirukset 10Respiratory infections: 63596 a) Bacteria: ^ -hemolytic streptococci, (group A), Haemophilus influenzae. Pneumococci, Mycoplasma 5 pneumoniae, mycobacteria b) Viruses: Influenza A, Influenza B, Parainfluenza 1-3, Respiratory syncytial virus, adenoviruses, coronaviruses, rhinoviruses 10

Ripulit: a) Bakteerit: Salmonella, Shigella, Yersinia entero-colitica, enterotoxigeeninen E. coli, Clostridium 15 di fficile, campylobakteerit b) Virukset: rotavirukset, parvovirukset, adenovirukset, enterovirukset 20 Sukupuolitaudit: a) Bakteerit: Neisseria gonorrhoeae, Treponema pallidum. Chlamydia trachomatis 25 b) Virukset: Herpes simplex -virus c) Hiivat: Candida albicans d) Alkueläimet: Trichomonas vaginalis 30Diarrhea: a) Bacteria: Salmonella, Shigella, Yersinia entero-colitica, enterotoxigenic E. coli, Clostridium 15 di fficile, campylobacter b) Viruses: rotaviruses, parvoviruses, adenoviruses, enteroviruses 20 Sexually transmitted diseases: a) Bacteria: Neisseria gonorrhoea Chlamydia trachomatis 25 b) Viruses: Herpes simplex virus c) Yeasts: Candida albicans d) Protozoa: Trichomonas vaginalis 30

Sepsis : a) Bakteerit: yj-hemolyyttinen streptococci, (A-ryhmä), Pneumococci, enterobakteerit ryhmänä 7 63596Sepsis: a) Bacteria: γ-hemolytic streptococci, (group A), Pneumococci, enterobacteria as group 7 63596

Elintarvi kehygienia: a) Bakteerit: salmonellat ja Clostridium perfringens 5 Riippuen reagenssien valinnasta testin spesifiteetti voidaan rajata mikrcbikohtaiseksi (esim. salmonellat) tai valitsemalla tunnistavat reagenssit kokonaiselle mikrobi-ryhmälle yhteisen geenin alueelta voidaan tunnistaa esimerkiksi koko enterobakteeriryhmä.Food hygiene: (a) Bacteria: Salmonella and Clostridium perfringens 5 Depending on the choice of reagents, the specificity of the test may be limited to microbes (eg salmonella) or by selecting recognizing reagents for an entire microbial group from a common gene region.

1010

Keksinnön mukaisessa kerroshybridisaatiotekniikassa tarvittavat nukleiinihapporeagenssit tuotetaan yhdistelmä-DNA-tekniikan avulla. Seuraavassa kuvataan esimerkki 1:ta varten tuotetut reagenssit ja testin suoritus.The nucleic acid reagents required in the layer hybridization technique of the invention are produced by recombinant DNA technology. The reagents produced for Example 1 and the performance of the test are described below.

1515

Reagenssitreagents

Adenovirus 2 (kanta säilytetty KTLsssä eli Kansanterveyslaitoksessa Helsingissä) kasvatetaan ja puhdistetaan 20 ja DNA eristetään (Petterson, U. & Sambrook, J. (1973) J. Mol. Biol. _73, 125 - 130) (kutsutaan Ad2-DNA: ksi) .Adenovirus 2 (strain stored in KTL, i.e. the Public Health Institute in Helsinki) is grown and purified and DNA is isolated (Petterson, U. & Sambrook, J. (1973) J. Mol. Biol. 73, 125-130) (referred to as Ad2 DNA). .

DNA hajotetaan BamHI - restriktioentsyymillä (BRL eli Bethesda Research Laboratories), joka katkaisee DNA:n neljään aina samanlaiseen fragmenttiin. Näistä neljästä 25 kaksi fragmenttia liitetään vektoriksi valitun pBR322-plasmidin (BRL) BamHI-katkaisukohtaan T4-ligaasientsyymin (BRL) avulla. (Fragmentteja ei erotettu toisistaan ennen ligaatiota, vaan plasmidin kulloinkin saama lisä - eli insertti - tunnistetaan vasta kloonauksen jälkeen.) 30 Tämän jälkeen plasmidi-DNA, jonka joukossa nyt on myös niin kutsuttuja rekombinanttiplasmideja eli sellaisia molekyylejä, jotka ovat hyväksyneet adenoviruksen DNA-jaksoja osikseen toivotulla tavalla, siirretään bakteeri - isäntään (E. coli HB101 (K12)(ga1 , pro , leu , hrs , hrm~, recA, 35 str , F )(KTL:Stä) transformaation avulla (Cohen, S.N. et ai. (1972) Proc. Natl. Acad. Soi. USA 69, 2110 - 2114). Transformoituneiden bakteerikloonien joukosta valitaan sellaiset, jotka todennäköisimmin sisältävät rekombi-nantti-plasmidin. Bakteeri saa pBR322-plasmidilta sekä __ - 1,.. .... - β 63596 ampisilliini- että tetrasykliiniresistenssigeenit (Bolivar, F. et ai. ( 1977) Gene £, 95-113). Rekombinanttiplasmidia sisältävät bakteerit taas ovat tetrasykliinilie herkkiä, koska BamHI-entsyymi katkaisee plasmidi-DNA:n tetrasyk-5 liiniresistenssigeenin alueelta ja tälle alueelle liittyvä vieras DNA tuhoaa geenin. Plasmidin saama insertti karakterisoidaan plasmidirikastuksen jälkeen BamHI-digestion avulla määrittämällä insertin koko agaroosigeelielektro-foreesin avulla. Reagensseiksi valitaan vierekkäiset 10 Ad2~DNA:n BamHI D- ja C-fragmentit (vrt. geenikartta), (Söderlund, H. et ai. ( 1976) Cell 7, 585 - 593). Oikeat, rekombinanttiplasmidit, Ad2C-pBR322, KTL n:oEH231 ja Ad2D-pBR322, KTL n:o EH230, kasvatetaan ja puhdistetaan kuten on kuvattu (Clewell, D.B. and Helinski, D.R. (1969) 15 Proc. Natl. Acad. Sei. USA 62, 1159 - 1166).The DNA is digested with the restriction enzyme BamHI (BRL, or Bethesda Research Laboratories), which cleaves the DNA into four identical fragments. Of these four, two fragments are ligated to the BamHI cleavage site of the vector selected as the vector pBR322 (BRL) using the T4 ligase enzyme (BRL). (The fragments were not separated before ligation, but the additional insert received by the plasmid - i.e. the insert - is not identified until after cloning.) Then plasmid DNA, which now includes so-called recombinant plasmids, i.e. molecules that have accepted adenovirus DNA sequences as part of it. as desired, is transferred to a bacterial host (E. coli HB101 (K12) (ga1, pro, Leu, hrs, hrm ~, recA, 35 str, F) (from KTL) by transformation (Cohen, SN et al. (1972 ) Proc. Natl. Acad. Soi. USA 69, 2110-2114) Among the transformed bacterial clones, those most likely to contain the recombinant plasmid are selected, the bacterium obtains from plasmid pBR322 and __ - 1, .. .... - β 63596 ampicillin and tetracycline resistance genes (Bolivar, F. et al. (1977) Gene®, 95-113) Bacteria containing the recombinant plasmid, on the other hand, are sensitive to tetracycline because the BamHI enzyme cleaves the tetracycline resistance of plasmid DNA. from the region and the foreign DNA associated with that region destroys the gene. The insert obtained by the plasmid is characterized after plasmid enrichment by BamHI digestion by determining the size of the insert by agarose gel electrophoresis. Adjacent BamHI D and C fragments of 10 Ad2 DNA (cf. gene map) are selected as reagents (Söderlund, H. et al. (1976) Cell 7, 585-593). The correct recombinant plasmids, Ad2C-pBR322, KTL No. EH231 and Ad2D-pBR322, KTL No. EH230, are grown and purified as described (Clewell, DB and Helinski, DR (1969) 15 Proc. Natl. Acad. Sci. USA). 62, 1159 - 1166).

Rekombinanttiplasmidi Ad2D-pBR322 käytetään sellaisenaan filtterireagenssiksi. Plasmidisekvenssejä ei tätä tarkoitusta varten tarvitse poistaa, koska näytteessä ei ole 20 pBR322-sekvenssejä. Sen sijaan radioaktiiviseksi leimattava nukleiinihapporeagenssi Ad2_BamHI C-fragmentti erotetaan pBR322-DNA:sta BamHI-digestion jälkeen agaroosi-geelielektroforeesin avulla. C-fragmentti eristetään LGT-agarase (Marine Colloids, Inc.) -geelistä fenoli-25 ekstraktion tai elektroeluution avulla (Wieslander, L.The recombinant plasmid Ad2D-pBR322 is used as such as a filter reagent. Plasmid sequences do not need to be deleted for this purpose because there are no 20 pBR322 sequences in the sample. Instead, the radiolabeled nucleic acid reagent Ad2_BamHI C fragment is separated from pBR322 DNA after BamHI digestion by agarose gel electrophoresis. The C fragment is isolated from an LGT agarase (Marine Colloids, Inc.) gel by phenol-25 extraction or electroelution (Wieslander, L.

( 1979) Anal. Biochem. 9_8, 305 - 309) ja konsentroidaan saostamalla etanolilla.(1979) Anal. Biochem. 9_8, 305-309) and concentrated by precipitation with ethanol.

Leimatuksi nukleiinihapporeagenssiksi valittava nukleiini-30 happofragmentti on erittäin tarkoituksenmukaista edelleen kloonata toiseen vektoriin, jolloin päästään eroon hybridisaatio taustasta, mikä johtuu leimattuun nukleiinihappo-reagenssiin epäpuhtautena jääneiden plasmidijaksojen suorasta hybridisaatiosta filtteriin. Tällainen opti-35 maalinen toinen vektori on yksisäikeinen DNA-faagi M13 mp7 (BRL), johon on helppo siirtää esimerkiksi BamHI-entsyymin avulla aikaansaatuja DNA-fragmentteja (Messing, 0. et ai.It is highly convenient to further clone the nucleic acid fragment to be selected as the labeled nucleic acid reagent into another vector to eliminate hybridization from the background due to direct hybridization to the filter of plasmid sequences remaining contaminated in the labeled nucleic acid reagent. One such second optical vector is the single-stranded DNA phage M13 mp7 (BRL), to which DNA fragments obtained, for example, by the BamHI enzyme are easily transferred (Messing, 0. et al.

(1981) Nucleic Acids Res. £, 309 - 323).(1981) Nucleic Acids Res. £, 309 - 323).

9 DNA:n kiinnitys filtterille 635969 Attachment of DNA to filter 63596

Rekombinanttiplasmidi Ad2Ö-pBR322 denaturoidaan yksisäi-keiseksi ja katkotaan sokeasti muutamasta kohdasta 0.2 N 5 NaOH-käsittelyllä (5 min 100°C), jonka jälkeen DNA jäähdytetään ja juuri ennen filtterille siirtoa neutraloidaan ja pipetoidaan siirtoliuokseen 4 x SSC -mediumiin jäillä (SSC = 0.15 M NaCl, 0.015 Π Na-sitraatti). Filtterit (Schleicher & Schull ΒΑΘ5 ni troselluloosa) kostutetaan 10 huolella 4 x SSC -liuoksessa (noin 2 t) ennen DNA-apli-kaatiota. DNA tartutetaan filtterille laimeassa liuoksessa (0.5 - 1 /ug/ml) suodattamalla liuos filtterin läpi lievässä vesi-imussa, jolloin DNA tarttuu. Filtteri kykenee sitomaan 0NA:ta noin 1Θ0 jug/cm (Kafatos, F.C.The recombinant plasmid Ad2Ö-pBR322 is denatured into a single strand and cleaved blindly at a few sites by 0.2 N 5 NaOH treatment (5 min at 100 ° C), after which the DNA is cooled and neutralized and pipetted into the transfer solution 4 x SSC medium on ice (SSC = 0.15) just before transfer to the filter. M NaCl, 0.015 Π Na citrate). Filters (Schleicher & Schull ΒΑΘ5 ni cellulose) are carefully wetted in 4 x SSC solution (approximately 2 h) before DNA application. The DNA is adhered to the filter in a dilute solution (0.5 to 1 ug / ml) by filtering the solution through the filter under gentle water suction, whereby the DNA adheres. The filter is capable of binding 0NA at about 1Θ0 μg / cm (Kafatos, F.C.

15 et ai. ( 1979] Nucleic Acids Research 7_, 1541 - 1552). Käytetään DNA-konsentraatioita 0.5 yug DNA:ta/ 2.5 cm halkaisijaltaan oleva filtteri aina 1 yugraan DNA:ta/7 mm halkaisijaltaan oleva filtteri. DNA-suoda-tuksen jälkeen filtterit pestään 4 x SSC:llä, kuivataan 20 huoneen lämmössä ja viimeksi käsitellään +80-asteisessa vakuumiuunissa 2 h, jonka jälkeen DNA säilyy niissä vakaana ja filtterit voidaan säilyttää huoneen lämmössä pitkiä aikoja (Southern, E.M. (1975) 0. Mol. Biol. 96, 503 - 51 7) .15 et al. (1979] Nucleic Acids Research 7, 1541-1552). DNA concentrations of 0.5 μg DNA / 2.5 cm diameter filter up to 1 μg DNA / 7 mm diameter filter are used. After DNA filtration, the filters are washed 4x with SSC, dried at 20 room temperature and last treated in a +80 ° C vacuum oven for 2 h, after which the DNA remains stable and the filters can be stored at room temperature for long periods (Southern, EM (1975)). 0. Mol Biol 96, 503 - 51 7).

2525

Radioaktiivisen nukleiinihappofragmentin leimaus 125Labeling of a radioactive nucleic acid fragment 125

Radioaktiivisena leimana käytetään I-isotooppia .The I isotope is used as the radiolabel.

30 Tämä on detektoitavissa Y~laskijalla, joka on olemassa useimmissa suurissa laboratorioyksiköissä. Isotoopin puoliintumisaika on 60 päivää, jonka takia tällä leimattujen reagenssien käyttöaika on noin 4 kk.30 This is detectable with the Y ~ counter that exists in most large laboratory units. The half-life of the isotope is 60 days, which is why the shelf life of the reagents labeled with this is about 4 months.

1 G1 G

63596 "Nie k-translation”-leimaus63596 “Nie k-translation” stamp

Menetelmän ideana on vaihtaa jokin nukleiinihapon nukleotideista radioaktiiviseksi , jolloin samalla koko DNA leimautuu. 5 Tämä tapahtuu Rigby, P.W.3. et al.:n (1977) 3. Mol. Biol. 113, 237 - 251) julkaiseman menetelmän mukaisesti. Reaktiossa DNA leimautuu radioaktiiviseksi, kun liuoksessa on 125 raaka-aineena I-isotoopi 11a leimattu dedksinukleosidi- 125 trifosfaatti, tässä tapauksessa I-dCTP (Radiochemical 10 Centre, Amersham: >1500 Ci/mmol). Optimaalisissa olo- 9 suhteissa DNA:han saadaan leimaa jopa 10 cpm yug DNA:ta kohti. Leimattu DNA puhdistetaan reaktiossa vapaaksi jääneistä nukleotideista yksinkertaisen geelisuodatuksen avulla, esim. käyttämällä BioGel P30:tä (BioRad).The idea of the method is to change one of the nucleotides of the nucleic acid to radioactive, at the same time labeling all the DNA. 5 This occurs in Rigby, P.W.3. et al. (1977) 3. Mol. Biol. 113, 237-251). In the reaction, the DNA is radiolabeled when the solution contains 125 I-isotope-labeled dedxinucleoside triphosphate as raw material, in this case I-dCTP (Radiochemical Center 10, Amersham:> 1500 Ci / mmol). Under optimal conditions, up to 10 cpm of DNA per DNA can be labeled. Labeled DNA is purified from nucleotides released in the reaction by simple gel filtration, e.g., using BioGel P30 (BioRad).

1515

Muu leimausOther stamping

Yksisäikeinen M13 mp7-faagissa tuotettava nukleiinihappo- 20 reagenssi on tarkoituksenmukaista leimata suoran jodee- 125 rauksen avulla, jolloin reaktiivinen I liitetään kova-lentisti nukleiinihappoon (Commerford, S.L. (1971) Biochemistry _1_0, 1993 - 2000, Orosz, J.M. and Wetmur, 3.G.The single-stranded nucleic acid reagent produced in M13 mp7 phage is conveniently labeled by direct iodination, with reactive I being hard-ligated to the nucleic acid (Commerford, SL (1971) Biochemistry _1_0, 1993-2000, Orosz, JM and Wetmur, 3). G.

( 1974) Biochemistry j_3, 5467 - 5473). Vaihtoehtoisesti 25 nukleiinihappo voidaan saattaa radioaktiiviseksi liittämällä sen päihin radioaktiivinen nukleotidi terminaalisen transferaasin avulla (Roychoudhury, R. and Wu, R. (19B0) Meth. Enzymol. 6_5, 43 - 62).(1974) Biochemistry j_3, 5467-5473). Alternatively, the nucleic acid can be radioactivated by attaching a radioactive nucleotide to its ends by terminal transferase (Roychoudhury, R. and Wu, R. (19B0) Meth. Enzymol. 6_5, 43-62).

30 Edellä käsitelty reagenssivalmistus koskee sellaisia mikrobeja, joiden perintöaines on DNA:ta. RNA-viruksien genomifragmenttien kloonaus tapahtuu siten, että ensin tehdään virus RNA:sta DNA-kopio (cDNA) reverse transkrip-taasientsyymin avulla, jonka jälkeen DNA-polymeraasi saat-35 taa DNA:n kaksisäikeiseksi ja DNA on kloonattavissa kuten yllä on esitetty (Salser, W. (1979) in Genetic Engineering, Ed. A.M. Chakrabarty, CRC Press, pp. 53 - 81).30 The reagent preparation discussed above concerns microbes whose genetic material is DNA. Cloning of RNA virus genomic fragments is accomplished by first making a DNA copy (cDNA) of the viral RNA using a reverse transcriptase enzyme, after which the DNA polymerase renders the DNA double-stranded and the DNA can be cloned as described above (Salser , W. (1979) in Genetic Engineering, Ed. AM Chakrabarty, CRC Press, pp. 53-81).

11 6359611 63596

Kunkin mikrobin kohdalla käytetään mahdollisimman tarkoituksenmukaista kloonausmenetelmää, jossa käytettävä vektori sekä isäntä voivat vaihdella. Kyseeseen voivat tulla λ-faagi vektorina, muut plasmidit, kosmidit, kloonaus 5 mm. Bacillus subtilis -bakteerissa jne. (Recombinant DNA, Benchmarck Papers in Microbiology, Voi. 15, Ed. K.3. Denniston & L.W. Enqvist, Dowden, Hutchinson & Ross, Inc. (19BDj Ish-Horowicz, D. and Burke, 3.F. (19813 Nucleic Acids Research j), 2989 - 29983 .For each microbe, the most appropriate cloning method is used, in which the vector used and the host may vary. Possible λ-phage vector, other plasmids, cosmids, cloning 5 mm. In Bacillus subtilis, etc. (Recombinant DNA, Benchmarck Papers in Microbiology, Vol. 15, Ed. K.3. Denniston & LW Enqvist, Dowden, Hutchinson & Ross, Inc. (19BDj Ish-Horowicz, D. and Burke, 3 .F (19813 Nucleic Acids Research j), 2989 - 29983.

1010

Testin suoritus Näytekäsittely 15Test performance Sample handling 15

Tutkittava mikrobinukleiinihappo on vapautettava sekä mikrobin sisältä että infektoiduista soluista ja denaturoitava yksisäikeiseen muotoon. Virusgenomit saadaan vapautetuiksi käsittelemällä näytemateriaali 1 %:sella nat-20 riumdodekyylisulfaattiliuoksella (SDS) ja hajottamalla niitä suojaavat proteiinit proteinaasi-K-käsittelyllä (1 mg/ml +37°, 60 min). Bakteerinäyte on näiden lisäksi hajotettava lysotsyymi- ja EDTA-käsittelyin .The microbinucleic acid to be examined must be released both inside the microbial and from the infected cells and denatured into a single-stranded form. Viral genomes are released by treating the sample material with 1% sodium dodecyl sulfate solution (SDS) and degrading their protective proteins by proteinase K treatment (1 mg / ml + 37 °, 60 min). In addition, the bacterial sample must be digested with lysozyme and EDTA.

25 3os näyte sisältää runsaasti sitkeää jättiläiskokoista solu-DNA:ta, tätä on katkottava sieltä täältä viskositeetin alentamiseksi esim. sonikoimalla tai puristamalla näyte ohuen neulan läpi muutamia kertoja.25 The 3s sample contains a lot of tough giant cellular DNA, this must be cut from here to here to reduce the viscosity, e.g. by sonicating or squeezing the sample through a thin needle a few times.

3030

Hybridisaatiohybridization

Hybridisaatio tapahtuu esimerkiksi 50 %:sessa formami-dissa (deionisoitu, säilytetty -20°C:ssa), 4 x SSC:ssä, 1 x 35 Denhardtin liuoksessa (Denhardt, D.T. (1966) Biochem.Hybridization occurs, for example, in 50% formamide (deionized, stored at -20 ° C), 4 x SSC, 1 x 35 Denhardt's solution (Denhardt, D.T. (1966) Biochem.

Biophys. Res. Commun. 2_3, 641 - 646), jossa on 1 % SDS sää ja 0,5 mg/ml DNAsta (salmon sperm tai calf thymus) +37°C:ssa 12 63596 yleensä yli yön 16 - 20 tuntia. Testiin valitut filtterit inkuboidaan sopivassa astiassa, johon pipetoidaan hybridi* saatioliuos ja hybridisaatio aloitetaan. Hybridisaatio* liuos koostuu (a) esikäsitellystä näytteestä ja tähän yhdis* 5 tetystä radioaktiivisesta nukleiinihapporeagenssista/rea* gensseista, jotka on denaturoitu keittämällä 5 minuuttia, jonka jälkeen liuos on nopeasti jäähdytetty 0°C:een; (b) konsentroiduista formamidi-, SSC- ja Denhardt*liuoksista, jotka pipetoidaan denaturoituun ja jäähtyneeseen 10 seokseen (a). Sekoituksen jälkeen hybridisaatioliuos pipetoidaan hybridisaatioastiaan filttereille. Hybridi* saation jälkeen filtterit pestään huolellisesti ja filtterit lasketaan yksitellen V-laskijassa.Biophys. Res. Commun. 2, 641-646) with 1% SDS weather and 0.5 mg / ml DNA (salmon sperm or calf thymus) at + 37 ° C 12,63596, usually overnight for 16-20 hours. The filters selected for the test are incubated in a suitable vessel into which the hybrid * solution is pipetted and hybridization is started. The hybridization * solution consists of (a) a pretreated sample and associated radioactive nucleic acid reagent (s) denatured by boiling for 5 minutes, after which the solution is rapidly cooled to 0 ° C; (b) concentrated formamide, SSC and Denhardt * solutions pipetted into the denatured and cooled mixture (a). After mixing, the hybridization solution is pipetted into the hybridization vessel for filters. After hybridization, the filters are washed thoroughly and the filters are counted one by one in a V-counter.

15 Keksintö selvennetään vielä muutamalla käyttöesimerkillä.The invention is further clarified by a few examples of use.

Esimerkki 1Example 1

Adenoviruksen detektio kerroshybridisaatio-menetelmän 20 avulla (Taulukko 1)Detection of adenovirus by layer hybridization method 20 (Table 1)

Testin yksityiskohdat selviävät taulukkotekstistä. Kerros-hybridisaatiomenetelmä kykenee osoittamaan virus-DNA:n liuoksesta, mutta yhtälailla virusgenomi on mahdollista 25 detektoida infektoiduista soluista.Details of the test can be found in the table text. The layer hybridization method is able to detect viral DNA from solution, but it is equally possible to detect the viral genome from infected cells.

Hybridisaation tausta mitataan putkessa, johon ei ole lisätty laisinkaan näytettä vaan ainoastaan filtteri ja leimattu nukleiinihapporeagenssi. Tausta johtuu leimatun nukleiini-30 happoreagenssin sisältämistä pBR322-jaksoista, jotka suoraan hybridisoituvat filtteriin ilman välittävää näytettä. Testissä kontrolleina käytetyt calf thymus ja tyhjät filtterit kuvaavat toisaalta hybridisaation spesifiteettiä ja toisaalta esim. pesujen riittämättömyydestä johtuvaa 35 epäspesifisen taustan suuruutta.The background of the hybridization is measured in a tube to which no sample has been added but only the filter and the labeled nucleic acid reagent. The background is due to the pBR322 sequences contained in the labeled nucleic acid acid reagent, which hybridize directly to the filter without a mediating sample. The calf thymus and empty filters used as controls in the test describe, on the one hand, the specificity of the hybridization and, on the other hand, the magnitude of the non-specific background due to, for example, insufficient washing.

Seuraavissa taulukoissa filttereille hybridisoituneista cpm-arvoista on vähennetty reagensseista johtuva tausta.In the following tables, the background due to reagents has been subtracted from the cpm values hybridized to the filters.

Taulukko 1 13 63596Table 1 13 63596

Adenovirustesti 5 Näyte Filtterit (cpm)Adenovirus Test 5 Sample Filters (cpm)

Adeno 1) Calf thymus 2) Blanko 3)Adeno 1) Calf thymus 2) Blanko 3)

Adenovirus 2-DNA (BRL) 10 (500 ng) 9000 49Adenovirus 2-DNA (BRL) 10 (500 ng) 9000 49

Adenoviruksella infektoidut HeLa-solut (6 x 10^) 8200 15Adenovirus-infected HeLa cells (6 x 10 ^) 8200 15

Filtterit; 13 Ad2D-pBR322-plasmidi 2 yug 2) Calf thymus DNA 1 yug (Boehringer Mannheim) 3) Blanko Cei DNA:ta) 20The filters; 13 Ad2D-pBR322 plasmid 2 yug 2) Calf thymus DNA 1 yug (Boehringer Mannheim) 3) Blanko Cei DNA) 20

Leimattu nukleiinihapporeagenssi;Labeled nucleic acid reagent;

Ad2_BamHI C-fragmentti puhdistettuna, spesifinen aktiviteetti 90 x 10^ cpm/^ig (200000 cpm ^"’i/reakt io) 25 Hybridisaatio:Ad2_BamHI C fragment purified, specific activity 90 x 10 ^ cpm / μg (200000 cpm ^ "'i / reaction) Hybridization:

50 % formamidi, 4 x SSC50% formamide, 4 x SSC

Denhardtin liuos, jossa 0,5 mg/ml salmon sperm DNA ja 1 % SDS, + 37°C, 16 t 30 Pesu; 0,1 x SSC, huoneenlämmössä 40 min Näytteet;Denhardt's solution with 0.5 mg / ml salmon sperm DNA and 1% SDS, + 37 ° C, 16 h 30 Wash; 0.1 x SSC, at room temperature 40 min Samples;

Adenovirus 2-DNA (BRL) 35 Adenovirus, tyyppiä 2 -infektio tapahtuu HeLa-soluissa. Solut hajoitetaan 1 % SDS-käsittelyllä, jonka jälkeen niille lisätään proteinaasi-K-entsyymi (Sigma) 1 mg/ml ja annetaan vaikuttaa +37°C:ssa 30 min. Ennen denatu-raatiota näyte puristetaan ohuen neulan läpi.Adenovirus 2-DNA (BRL) 35 Adenovirus, type 2 infection occurs in HeLa cells. The cells are lysed by 1% SDS treatment, followed by the addition of proteinase K enzyme (Sigma) 1 mg / ml and allowed to act at + 37 ° C for 30 min. Prior to denaturation, the sample is squeezed through a thin needle.

14 6359614 63596

Taulukon arvoista on vähennetty reagenssien aiheuttama tausta, joka on saatu vastaavasta hybridisaatiosta ilman näytettä.From the values in the table, the background caused by the reagents obtained from the corresponding hybridization without sample has been subtracted.

5 Esimerkki 2 RNA-yiruksen detektio kerroshybridisaatiomenetelmän avulla (taulukko 2) 10 RNA-virusmalIina käytetään Semliki Forest virusta (proto-tyyppikanta, saatu London School of Hygiene and Tropical Medicine'Itä), jonka genomi on yksisäikeistä RNArta.5 Example 2 Detection of RNA virus by the layer hybridization method (Table 2) 10 The RNA virus model used is Semliki Forest virus (prototype strain obtained from the London School of Hygiene and Tropical Medicine) whose genome is single-stranded RNA.

Virusgenomia mallina käyttäen valmistetaan cDNA, joka kloonataan pBR322-plasmidiin sen Pstl-katkaisukohtaan kuten 15 Garoff et ai. ovat kuvanneet (Proc. Natl. Acad. Sei. (1980) USA 77 6376 - 6380). Saatu rekombinanttiplasmidi on pKTH312 KTL n:o EH 232. Sen virusgenomista peräisin oleva osa on noin 1400 nukleotidia pitkä ja peräisin viruksen rakenneproteiinien alueelta, noin nukleotidista 200 20 nukleotidiin 1600, kun numerointi aloitetaan rakennegeeni-en alusta (Garoff, H. et ai. 1980). Reagenssivalmistusta varten koko rekombinanttiplasmidi pKTH312 linearisoidaan EcoRI-restriktioentsyymi1lä (BRL) (Semliki Forest viruksesta peräisin olevissa sekvensseissä ei ole EcoRI-entsyymin 25 tunnistuskohtaa), ja tämä puolestaan katkaistaan kahdeksi fragmentiksi XhoI-entsyymillä (BRL), jonka katkaisukohta paikantuu Semliki Forest viruksen sekvenssien alueelle. Suurempi EcoRI - XhoI-fragmentti A (noin 3900 emäsparia pitkä) kiinnitetään filtterille, kun pienempi fragmentti 125 30 B (noin 1850 emäsparia pitkä) leimataan I:lla nick translaation avulla.Using the viral genome as a template, cDNA is prepared and cloned into plasmid pBR322 at its PstI cleavage site as described by Garoff et al. have described (Proc. Natl. Acad. Sci. (1980) USA 77 6376-63880). The resulting recombinant plasmid is pKTH312 KTL No. EH 232. Its viral genome-derived portion is about 1400 nucleotides in length and originates in the region of viral structural proteins, from about nucleotide 200 to nucleotide 1600 when numbering begins at the beginning of structural genes (Garoff, H. et al. 1980 ). For reagent preparation, the entire recombinant plasmid pKTH312 is linearized with EcoRI restriction enzyme (BRL) (sequences derived from Semliki Forest virus do not have 25 EcoRI recognition sites), which in turn is cleaved into two fragments by the XhoI site (BRL). The larger EcoRI-XhoI fragment A (about 3900 bp in length) is attached to the filter when the smaller fragment 125 B (about 1850 bp in length) is labeled with I by nick translation.

Näytteenä kokeessa käytetään sekä kokonaista Semliki Forest virusta että Semliki Forest viruksella infektoituja soluja. 35 Molemmissa tapauksissa näytteen virusspesifiset nukleiinihapot koostuvat yksinomaan RNArsta.Both whole Semliki Forest virus and Semliki Forest virus-infected cells are used as samples in the experiment. 35 In both cases, the virus-specific nucleic acids in the sample consist exclusively of RNA.

Taulukko 2 15 63596Table 2 15 63596

Semliki Forest viruksen detektio kerroshybridisaatiomenetel-män avulla 5 __ Näyte Filtterit (cpm)Detection of Semliki Forest virus by layer hybridization 5__ Sample Filters (cpm)

Semliki Forest Calf thymus 2) Blanko 3) virus 1) 10 Semliki Forest virus 30 ^ig 3340 - 33Semliki Forest Calf thymus 2) Blanko 3) virus 1) 10 Semliki Forest virus 30 ^ to 3340 - 33

Semliki Forest viruksella infektoidut solut (5 x 105) 2698 8 10 15Semliki Forest virus infected cells (5 x 105) 2698 8 10 15

Ei infektoidut solut 10 5 8Uninfected cells 10 5 8

Filtterit; 20 1) pKTH312 plasmidin EcoRI-XhoI-fragmentti A 1,2 jug 2) Calf thymus DNA 1 /jg 3) Blanko (ei DNA:ta)The filters; 1) EcoRI-XhoI fragment A of plasmid pKTH312 A 1.2 [mu] g 2) Calf thymus DNA 1 / [mu] g 3) Blank (no DNA)

Leimatut nukleiinihapporeagenssit: 25 Plasmidin pKTH312 EcoRI-XhoI-fragmentti B, spesifinen c λ y c aktiviteetti 90 x 10 cpm//ug DNA (200000 cpm I/reaktio)Labeled nucleic acid reagents: EcoRI-XhoI fragment B of plasmid pKTH312, specific c λ y c activity 90 x 10 cpm // ug DNA (200,000 cpm I / reaction)

Hybridisaatio:hybridization:

Kuten esimerkissä 1 30As in Example 1 30

Pesu;Washing;

Kuten esimerkissä 1 Näytteet; 35 Semliki Forest virus 30 /jg hajoitetaan. SDS:llä ennen testiä. Infektoidut solut käsitellään kuten esimerkissä 1 on selostettu. Semliki Forest virusinfektio suoritetaan BHK-21-soluissa.As in Example 1 Samples; 35 Semliki Forest virus 30 μg is digested. With SDS before the test. Infected cells are treated as described in Example 1. Semliki Forest virus infection is performed in BHK-21 cells.

i ' l 16 63596i 'l 16 63596

Taulukon 2 arvoista on vähennetty reagenssien aiheuttama tausta, joka on saatu vastaavasta hybridisaatiosta ilman näytettä.From the values in Table 2, the reagent-induced background obtained from the corresponding hybridization without sample has been subtracted.

5 Esimerkki 35 Example 3

Virusnäyte, jossa viruksen lähetti-RNA detektoidaan kerros hybridisaati omenetelmän avulla (taulukko 3) 10 Kerroshybridisaatioreagenssit valmistetaan SV40-viruksen DIMA:sta (BRL) siten, että DNA katkaistaan kahteen palaanVirus sample in which viral messenger RNA is detected by the layer hybridization method (Table 3) 10 Layer hybridization reagents are prepared from SV40 virus DIMA (BRL) by cutting the DNA into two pieces.

Pstl-entsyymin (Baehringer Mannheim) avulla (Lebowitz, P.Using the PstI enzyme (Baehringer Mannheim) (Lebowitz, P.

and Weissman, S.M. (1979) Curr. Topics in Microbiol.and Weissman, S.M. (1979) Curr. Topics in Microbiol.

Immunol, 8_7, 43 - 172) ja fragmentit eristetään ja puhdiste-Immunol, 8-7, 43-172) and fragments are isolated and purified

15 taan agaroosigeelielektroforeesin avulla. Fragmentti A15 by agarose gel electrophoresis. Fragment A

(4000 emäsparia) leimataan radioaktiiviseksi nick-trans-125 laatiossa I:llä ja fragmentti B (1220 emäsparia) kiinnitetään filtterille.(4000 bp) is radiolabeled in nick-trans-125 with I and fragment B (1220 bp) is attached to a filter.

20 ONA-fragmentit on valittu siten, että molemmissa on sekä myöhäisiä että aikaisia lähettejä koodittavia alueita. Niinpä B sisältää noin 700 emästä rakenneproteiini VP1:n geenistä ja yli 600 emästä aikaisten lähettien geenistä. Koska SV40-viruksen DNA sinänsä on kovalentisti suljettu 25 rengas, se ei sovellu testissä näytteeksi ilman, että se avataan lineaariseksi. Niinpä käytettäessä infektoituja soluja näytteenä voidaan testata, kuinka hyvin menetelmä soveltuu virusgenomin mukaan tehtyjen RNA-kopioiden osoittamiseen. Taulukosta 3 ilmenee, että testi soveltuu 30 erinomaisesti infektoitujen solujen tutkimiseen. Se demonstroi myös, että samoilla reagenssei1la voidaan tutkia sekä itse virus-DNA että sen mukaan tehdyt lähetti-RNAst.The ONA fragments are selected so that both have regions encoding both late and early transmissions. Thus, B contains about 700 bases of the structural protein VP1 gene and more than 600 bases of the early messenger gene. Because SV40 virus DNA itself is a covalently closed 25 ring, it is not suitable as a sample in the assay without being opened linearly. Thus, by using infected cells as a sample, it can be tested how well the method is suitable for detecting RNA copies made according to the viral genome. Table 3 shows that the test is suitable for examining 30 excellently infected cells. It also demonstrates that the same reagents can be used to examine both the viral DNA itself and the resulting messenger RNAs.

6359663596

Taulukko 3 1 7 SV40-virusten detektio kerroshybri-'disaatiomenetR·] mäi ι·ή 5 Näyte Filtterit (cpm) SV40 1) Calf thymus 2) Blanko 3)Table 3 1 7 Detection of SV40 viruses by layer hybridization procedures · sample 5 Filters (cpm) SV40 1) Calf thymus 2) Blanko 3)

Koe 1 SV4Q-virus-DNA (50 ng) 10 (linearisoitu) 20061 159 104Experiment 1 SV4Q virus DNA (50 ng) 10 (linearized) 20061 159 104

Ei näytettä - 1 5 Koe 2 SV40-viruksella infektoidut CV1-solut 40 t infektion jälkeen (10^ solua) 30814 294 530 20 Ei infektoidut solut -No sample - 1 5 Experiment 2 CV1 cells infected with SV40 virus 40 h after infection (10 ^ cells) 30814 294 530 20 Uninfected cells -

Filtterit: 1) SV40-viruksen sirkulaarisesta DNA:sta Pstl-restriktio- 25 entsyymillä katkaistu lyhyempi fragmentti PstI B 0,2 yug 2) Calf thymus DNA 1 /Jg 3) Blanko (ei DNA:ta)Filters: 1) Shorter fragment of SV40 virus circular DNA cleaved by PstI restriction enzyme PstI B 0.2 yug 2) Calf thymus DNA 1 / Jg 3) Blanko (no DNA)

Leimattu nukleiinihapporeagenssi: 30 sV40-viruksen-DNA:sta peräisin oleva pitempi PstI A-fragmentti, spesifinen aktiviteetti 28 x 106 cpm//Jg DNA (200000 cpm 125I/reaktio)Labeled Nucleic Acid Reagent: Longer PstI A fragment from 30 sV40 viral DNA, specific activity 28 x 106 cpm // Jg DNA (200,000 cpm 125I / reaction)

Hybridisaatio:hybridization:

Kuten esimerkissä 1 35 Hybridisaatioaika on 40 tuntiaAs in Example 1, the hybridization time is 40 hours

Pesu;Washing;

Kuten esimerkissä 1 18 63596 Näytteet: SV40-virus-DNA (BRL) on linearisoitu EcoRI- restriktioentsyymin (BRL) avulla. CV1-solut (Biomedical Centre, Upsala University) infektoidaan SV40-viruksella (saatu Janice Y.As in Example 1 18 63596 Samples: SV40 viral DNA (BRL) is linearized with EcoRI restriction enzyme (BRL). CV1 cells (Biomedical Center, Uppsala University) are infected with SV40 virus (obtained from Janice Y.

5 Chou & Robert G. Martinilta, NIH, Bethesda) ja solut kerätään 48 tuntia infektion jälkeen. Näytekäsittely tapahtuu kuten esimerkissä 1.5 from Chou & Robert G. Martin, NIH, Bethesda) and cells are harvested 48 hours after infection. Sample processing is performed as in Example 1.

Taulukon 3 arvoista on vähennetty reagenssien aiheuttama 10 tausta, joka on saatu vastaavasta hybridisaatiosta ilman näytettä.From the values in Table 3, the background caused by the reagents obtained from the corresponding hybridization without sample has been subtracted.

Esimerkki 4 15 Bacillus amyloliquefaciensin detektio kerroshybridisaatio-menetelmän avulla (Taulukko 4)Example 4 Detection of Bacillus amyloliquefaciens by the layer hybridization method (Table 4)

Reagensseina on käytetty B. amyloliquefacjens* in E18 (VTT eli Valtion Teknillinen Tutkimuslaitos) o(-amylaasigeenin 20 fragmentteja, jotka on tätä testiä varten eristetty rekombi-nanttiplasmidi pKTH10:stä (Palva, I. et ai, (19Θ1) Gene, V5 43.-5 T) restri ktioentsyymikäsittelyn jälkeen agaroosigeeli-elektoroforeesin avulla. Testiä varten käytetyt fragmentit ovat 0(-amy laasigeenialueen Cla!>EcoRI-f ragmentti , (460 25 emäsparia) (Clal Boehringer Mannheim) ja EcoRI-BamHI-frag~ mentti (1500 emäsparia). Näistä EcoRI-BamHI-fragmentti kiinnitetään filtterille ja Clal-EcoRI-fragmentti leima*· taan l*L-li-isotaopi 1 la radioaktiiviseksi nick-translaation avu 1la.As reagents, fragments of the o (-amylase gene) of B. amyloliquefacjens * in E18 (VTT or State Technical Research Institute) isolated from the recombinant plasmid pKTH10 for this test have been used (Palva, I. et al., (19Θ1) Gene, V5 43 .-5 T) after restriction enzyme treatment by agarose gel electrophoresis The fragments used for the assay are the 0 (-amylase gene region ClaI> EcoRI fragment, (460 25 bp) (Clal Boehringer Mannheim) and the EcoRI-BamHI fragment ( Of these, the EcoRI-BamHI fragment is attached to a filter and the ClaI-EcoRI fragment is labeled with 1 * L-li isotope 11a radioactively by nick translation.

3030

Taulukosta 4 käy ilmi, että kerroshybridisaatiotekniikan avulla B. amyloliquefaciens on tunnistettavissa näytteestä sen sisältämän yhden (X-amylaasigeenin perusteella. E. coli oli testissä negatiivinen (antoi taustaan rinnastettavan 35 tuloksen).Table 4 shows that by the layer hybridization technique, B. amyloliquefaciens can be identified in the sample by one (based on the X-amylase gene. E. coli was negative in the test (gave a result comparable to 35 in the background).

19 6359619 63596

Taulukko 4Table 4

Bakteeridiagnostiikka kerroshybridisaation avulla 5 Näyte Filtterit (cpm) 0(-amylaasi 1] Calf thymus 2) Blanko 3)Bacterial diagnostics by layer hybridization 5 Sample Filters (cpm) 0 (-amylase 1] Calf thymus 2) Blanko 3)

pKTHlQ-plasmidi-DNApKTHlQ plasmid DNA

(linearisoitu) 1 μg 5773 47 10(linearized) 1 μg 5773 47 10

Ei näytettä - E. coli HB101 (109) - - 1 5 Bacillus amylolique- faciens (3 x 10 ) 3377No sample - E. coli HB101 (109) - - 1 5 Bacillus amylolique- faciens (3 x 10) 3377

Bacillus amylolique- faciens (109) 2871 20 _I___Bacillus amylolique- faciens (109) 2871 20 _I___

Filtterit; 1) pKTH10-plasmidin (X-amylaasigeenin EcoRI-BamHI-fragmentti 0,35 yug 25 2) Calf thymus DNA 1 ^ug 31 Blanko (ei DNA:ta)The filters; 1) Plasmid pKTH10 (EcoRI-BamHI fragment of the X-amylase gene 0.35 μg 25 2) Calf thymus DNA 1 μg 31 Blanko (no DNA)

Leimattu nukleiinihapporeagenssi: pKTHIO-plasmidin CV-amy laasigeenin Clal-EcoRI-f ragmentti , 6 125 30 spesifinen aktiivisuus 35 x 10 cprrv^ug (200000 cpm I/reaktio)Labeled nucleic acid reagent: ClaI-EcoRI fragment of the CV-Amy lasal gene of the pKTHIO plasmid, 6 125 30 specific activity 35 x 10 cprrv ug (200,000 cpm I / reaction)

Hybridisaatio:hybridization:

Kuten esimerkissä 1 35 Pesu:As in Example 1 35 Washing:

Kuten esimerkissä 1 20 63596 Näytteet:As in Example 1 20 63596 Samples:

Bakteerinäytteet käsitellään lysotsyyrai 1 lä (67 yug/ml) 30 min +37°C; E. coli näytteeseen lisätään myös 5 mM EDTA. Käsittelyn loputtua kaikille näytteille lisätään SDS (2 %), 5 näytteet puristetaan ohuen neulan läpi kaksi kertaa viskositeetin alentamiseksi ja denaturoidaan keittämällä, kuten on kuvattu tekstissä näytekäsittelyn yhteydessä.Bacterial samples are treated with lysocyr (1 μg / ml) for 30 min at + 37 ° C; 5 mM EDTA is also added to the E. coli sample. At the end of the treatment, SDS (2%) is added to all samples, the samples are pressed through a thin needle twice to reduce the viscosity and denatured by boiling as described in the text during sample processing.

Taulukon 4 arvoista on vähennetty reagenssien aiheuttama 10 tausta, joka on saatu vastaavasta hybridisaatiosta ilman näytettä.From the values in Table 4, the background caused by the reagents 10 obtained from the corresponding hybridization without sample has been subtracted.

Esimerkki 5 15 Esimerkki kerroshybridisaatiomenetelmään perustuvasta "kittinä” toimivasta reagenssien yhdistelmästä (taulukko 5) Näytteinä tällä testillä tutkitaan kolmella eri viruksella infektoituja soluja (adenovirus, SV40 virus ja Herpes 20 simplex virus) sekä Bacillus amyloliquefaciens-bakteeria sisältävä näyte. Kuhunkin näytteeseen sekoitetaan yhtäaikaisesti kaikki seuraavat reagenssit: filttereistä 1 kpl SV40-virus, adenovirus-, Bacillus amyloliquefaciensin Λ-amylaasigeeni- ja calf thymus-DNA:ta sisältävä filtteri 25 sekä yksi tyhjä filtteri; näiden lisäksi 200000 cpm kutakin seuraavista leimatuista nukleiinihapporeagensseista: SV40-virus-, adenovirus- ja 0(-amylaasigeeni-DNA-reagenssit,Example 5 Example of a combination of reagents acting as a "putty" based on the layer hybridization method (Table 5) As samples in this test, cells infected with three different viruses (adenovirus, SV40 virus and Herpes 20 simplex virus) and Bacillus amyloliquefaciens are all sampled into each sample. reagents: 1 filter containing SV40 virus, a filter containing 25 adenovirus, Bacillus amyloliquefaciens am-amylase gene and calf thymus DNA and one empty filter, in addition to 200000 cpm of each of the following labeled nucleic acid reagents: SV40 virus and adenovirus 0 (-amylaasigeeni DNA reagents,

Esimerkkimme osoittaa, että näytteestä voidaan sitä laimen-30 tamatta ja jakamatta tutkia samalla kertaa tarkoituksenmukainen sarja mikrobeja sekoittamalla reagenssit näytteeseen. Näytteenä voi toimia sekä virus- että bakteerinukleiinihappo. Näytteessä olevan mikrobin identifiointi on helppoa, koska se tapahtuu tunnuksilla 35 varustettujen filttereiden perusteella.Our example shows that an appropriate set of microbes can be tested on a sample at the same time without diluting and dividing it by mixing the reagents in the sample. Both viral and bacterial nucleic acid can serve as samples. The identification of the microbe in the sample is easy because it is done on the basis of filters marked 35.

Taulukko 5 21 63596Table 5 21 63596

Kerroshybridisaatiomenetelmään perustuva kit 5 Näyte Filtterit (cpm) SV40 1) Adeno 2) 0(-arry- Calf Blanko 5) laasi 3) thymus 4) SV40-viruksella irifek- 10 toidut solut MO6) 16390 2 13 22 31Kit based on the layer hybridization method 5 Sample Filters (cpm) SV40 1) Adeno 2) 0 (-arry- Calf Blanko 5) glass 3) thymus 4) SV40 virus irifinfected cells MO6) 16390 2 13 22 31

Adeno-2-viruksella infektoidut solut (6 x 105) - 6750 5 13 15Cells infected with Adeno-2 virus (6 x 105) - 6750 5 13 15

Herpes simplex-viruk-sella infektoidut solut MO6) - 5 13 20 Bacillus amylolique- faciens MQ9) 15 8 6500 16 5Cells infected with the herpes simplex virus MO6) - 5 13 20 Bacillus amylolique- faciens MQ9) 15 8 6500 16 5

Ei infektoidut solut 25Uninfected cells 25

Filtterit; 1) kuten esimerkissä 3 2) kuten esimerkissä 1 3) kuten esimerkissä 4 30 4) Calf thymus DNA 1 yug 5) Blanko (ei DNA:ta)The filters; 1) as in Example 3 2) as in Example 1 3) as in Example 4 30 4) Calf thymus DNA 1 yug 5) Blanko (no DNA)

Leimatut nukleiinihapporeagenssit: SV40“virus kuten esimerkissä 3 35 Adenovirus kuten esimerkissä 1 (X-amy laasi geeni kuten esimerkissä 4 22Labeled nucleic acid reagents: SV40 virus as in Example 3 35 Adenovirus as in Example 1 (X-Amy glass gene as in Example 4 22

Hybridisaatio; 63596hybridization; 63596

Kuten esimerkissä 1 Pesu: 5 Kuten esimerkissä 1 Näytteet: SV40 viruksella infektoidut solunäytteet on selostettu taulukossa 3. Adenoviruksella infektoidut solunäytteet 10 on selostettu taulukossa 1.As in Example 1 Washing: 5 As in Example 1 Samples: SV40 virus infected cell samples are described in Table 3. Adenovirus infected cell samples 10 are described in Table 1.

00

Herpes simplex, tyyppiä 1 viruksella infektoidaan 10 Vero-solua. Solut kerätään näytteeksi 20 tunnin kasvatuksen jälkeen, kun soluissa voidaan mikroskooppisesti havaita 15 virusinfektion merkit. Näyte käsitellään samoin kuin adenoviruksella infektoidut solut (esimerkki 1).Herpes simplex, a type 1 virus, infects 10 Vero cells. Cells are harvested after 20 hours of culture, when microscopic signs of viral infection can be detected in the cells. The sample is treated in the same way as adenovirus-infected cells (Example 1).

Bacillus amyloliquefaciens näyte:Sample of Bacillus amyloliquefaciens:

Kuten taulukossa 4 20As in Table 4 20

Taulukon 5 arvoista on vähennetty reagenssien aiheuttama tausta, joka on saatu vastaavasta hybridisaatiosta ilman näytettä.From the values in Table 5, the reagent-induced background obtained from the corresponding hybridization without sample has been subtracted.

Il 63596 23 5Il 63596 23 5

Esimerkki 6Example 6

Escherichia colin detektio kerroshybridisaatiomenetelmän avu 11a (Taulukko 6)Detection of Escherichia coli by the layer hybridization method 11a (Table 6)

Testireagenssit valmistettiin E. colin ompA-geenin fragmenteista. OmpA (outer memhrane protein A) on E. colin ulko-membraaniprotei i ni.Test reagents were prepared from fragments of the E. coli ompA gene. OmpA (outer memhrane protein A) is an outer membrane protein of E. coli.

10 Lähtömateriaalina käytettiin SITRA:n yhdistelmä-DNA-ryhmän (Pauli Kallio, pro gradu-tutkielma, Helsingin yliopiston yleisen mikrobiologian laitos) pTU100 plasmidista (Henning et ai. ( 1979), proc. Natl. Acad. Sei. U.S.A. 7_6, 4360-4364) prosessoimia hybridiplasmideja pKTH40 ja pKTH45.10 The plasmid pTU100 from the SITRA recombinant DNA group (Pauli Kallio, master's thesis, Department of General Microbiology, University of Helsinki) (Henning et al. (1979), Proc. Natl. Acad. Sci. USA 7_6, 4360-) was used as starting material. 4364) processed hybrid plasmids pKTH40 and pKTH45.

15 pKTH45-plasmidia (deponoitu KTLrlle no:lla EH254), joka sisältää 740 emäsparia ompA-geenin 5’ -päästä pBR322-plasmidiin liitettynä, käytettiin suoraan filtterireagens-s ina.Plasmid pKTH45 (deposited with KTL No. EH254) containing 740 base pairs from the 5 'end of the ompA gene fused to plasmid pBR322 was used directly as a filter reagent.

20 pKTH40-plasmidi sisältää noin 300 emäsparia ompA-geenin 3' -päästä ja sitä välittömästi seuraavat noin 1400 emäs-paria E. colin muuta genomia. pKTH40 pilkottiin BamHI restriktioentsyymillä, jolloin saatiin yhteensä 1700 25 emäsparia käsittävä E. colista peräisin oleva DNA-frag* mentti. Se siirrettiin yksisäikeiseen bakteriofaagiin M13mp7 (Messing et ai. (19B1), Nucl. Acids Res. £, 309-321, Heidecker et ai. (19Θ0), Gene _1_0, 69-73, Gardner et ai. (19Θ1), Nucl. Acids Res. £, 2871-286Θ). Saatua yhdistel-30 mäfaagia, mKTH12Q7 (deponoitu KTL:lle noilla EH256), käytettiin kerroshybridisaatiossa koettimena leimaamalla 12 5 se J-isotoopilla radioaktiiviseksi kuten on kuvattu kohdassa "Muu leimaus" sivu 9.Plasmid pKTH40 contains about 300 base pairs from the 3 'end of the ompA gene, immediately followed by about 1400 base pairs from the rest of the E. coli genome. pKTH40 was digested with the restriction enzyme BamHI to give a DNA fragment from E. coli of a total of 1700 25 base pairs. It was transferred to single-stranded bacteriophage M13mp7 (Messing et al. (19B1), Nucl. Acids Res. E, 309-321, Heidecker et al. Acids Res., 2871-286Θ). The resulting recombinant mage phage, mKTH12Q7 (deposited on the KTL with those EH256), was used in layer hybridization as a probe by labeling it with a J-isotope radioactive as described in "Other Labeling" on page 9.

35 Kuten testistä (taulukko 6) ilmenee, voidaan sekä rikot- tujen E. coli solujen DNA että E. colista eristetty puhdas DNA detektoida kerroshybridisaatiomenetelmän avulla.As shown in the assay (Table 6), both DNA from disrupted E. coli cells and pure DNA isolated from E. coli can be detected by a layer hybridization method.

Taulukko 6 24 63596Table 6 24 63596

Escherichia coli-bakteerin detektio kerroshybridisaatio’· menetelmän avulla 5 __ Näyte Filtterit (cpm) ompA 1) Calf thymus 2) Sianko 3) E. coli K12 HB101'DNA 10 a) 2 x 107 282Detection of Escherichia coli by the layer hybridisation method · __ Sample Filters (cpm) ompA 1) Calf thymus 2) Pig 3) E. coli K12 HB101'DNA 10 a) 2 x 107 282

E. coli K12 HB101 DNAE. coli K12 HB101 DNA

a) 2 x 108 2206 15 E. coli K12 HB101 solut b) 2 x 107 1113 E. coli K.12 HB101 solut b) 2 x 10® 2327 12 5 20 _____ a) DNA-molekyylien lukumäärä, b) solujen lukumääräa) 2 x 108 2206 15 E. coli K12 HB101 cells b) 2 x 107 1113 E. coli K.12 HB101 cells b) 2 x 10® 2327 12 5 20 _____ a) Number of DNA molecules, b) Number of cells

Filtterit: 25 1) pKTH45 plasmidi 1,088 jug (2 x 10^ molekyyliä) 2) Calf thymus DNA 1,088 ;ug 3) Blanko (ei DNA:ta)Filters: 25 1) pKTH45 plasmid 1.088 μg (2 x 10 ^ molecules) 2) Calf thymus DNA 1.088; ug 3) Blanko (no DNA)

Leimatut nukleiinihapporeagenssit; 30 mKTH 1207, spesifinen aktiviteetti 8 x 107 cpm/jug DNA (200000 cpm/reaktio)Labeled nucleic acid reagents; 30 mKTH 1207, specific activity 8 x 107 cpm / μg DNA (200,000 cpm / reaction)

Hybridisaatio; 4 x SSC, 1 x Denhardt ilman BSA:ta (bovin serum albumin),hybridization; 4 x SSC, 1 x Denhardt without BSA (bovin Serum album),

35 0,25 % SDS, 200 /ug/ml Herring sperm DNA, 17,5 h, ♦65°C0.25% SDS, 200 ug / ml Herring sperm DNA, 17.5 h, ♦ 65 ° C

Pesu;Washing;

Kuten esimerkissä 1 63596 25 Näytteet: E. coli K12 HB101 - DNA eristettiin Marmur-menetelmälla (Marmur (1961), J. Mol. Biol. 3, 208-21Θ). DNA:n denatu-raatio testiä varten tehtiin 7 mM NaGH, 100 C, 5 min.As in Example 1 63596 Samples: E. coli K12 HB101 DNA was isolated by the Marmur method (Marmur (1961), J. Mol. Biol. 3, 208-21Θ). DNA denaturation for the assay was performed with 7 mM NaGH, 100 ° C, 5 min.

5 Solut hajotettiin lysotsyymi (500 /jg/ml), EDTA (70 mM, + 37°C, 30 min), SOS (0,25 %, +65°C, 15 min) käsittelyllä ja vapautunut DNA denaturoitiin alkalikeitolla (14 mM NaOH, +100°C, 5 min).Cells were lysed by treatment with lysozyme (500 μg / ml), EDTA (70 mM, + 37 ° C, 30 min), SOS (0.25%, + 65 ° C, 15 min) and the released DNA was denatured with alkaline soup (14 mM NaOH, + 100 ° C, 5 min).

10 Taulukon 6 arvoista on vähennetty reagenssien aiheuttama tausta, joka on saatu vastaavasta hybridisaatiosta ilman näytettä.From the values in Table 6, the background caused by the reagents obtained from the corresponding hybridization without sample has been subtracted.

Claims (10)

26 6359626 63596 1. Nukleiinihappojen kerroshybridisaatioon kiinteällä kantajalla perustuva mikrobidiagnostinen menetelmä yhden tai 5 useamman mikrobin ja/tai mikrobiryhmän yhtäaikaiseksi tunnistamiseksi, jossa menetelmässä käytetään kahta erilaista nukleiinihapporeagenssia, joista toinen käsittää yksisäi-keisenä kiinteään kantajaan sidotun nukleiinihappofragmentin ja toinen käsittää yksisäikeiseksi saatetun jollakin merk-10 kiaineella leimatun nukleiinihappofragmentin, tunnet-t u siitä, että sarja, joka koostuu vähintään kahdesta eri nukleiinihapporeagenssista jokaista tunnistettavaksi tarkoitettua mikrobia ja/tai mikrobi ryhmää kohden ja joista reagensseista toinen on sidottu kiinteään kantajaan ja 15 toinen leimattu sinänsä tunnetulla merkkiaineella, saatetaan kosketukseen yhdessä jakamattomassa näytteessä olevien tunnistettaviksi tarkoitettujen mikrobien tai mikrobiryhmien sinänsä tunnetulla tavalla yksisäikeisiksi saatettujen nukleiinihappojen kanssa, jolloin näytteestä 20 peräisin olevasta nukleiinihapposeoksesta ne nukleiinihapot, joita vastaavia nukleiinihapporeagensseja käytetään, hybridisoituvat kiinteään kantajaan sidottuihin vastaaviin tunnistaviin nukleiinihappofragmentteihin ja muodostuneet kiinteään kantajaan tartutetut hybridit leimautuvat vastaa-25 vien leimattujen nukleiinihappofragmenttien avulla näiden sitoutuessa näytteestä peräisin oleviin kiinteään kantajaan sitoutuneihin nukleiinihappoihin ja kiinteän kantajan leimaus mitataan sinänsä tunnetuin menetelmin.A solid-state microbial diagnostic method based on layered hybridization of nucleic acids to simultaneously identify one or more microbes and / or groups of microbes, comprising two different nucleic acid reagents, one comprising a single-stranded nucleic acid , characterized in that a series of at least two different nucleic acid reagents for each microbial and / or microbial group to be identified, one bound to a solid support and the other labeled with a label known per se, is contacted with one of the undivided samples. with single-stranded nucleic acids of microbes or groups of microbes in a manner known per se, in which case the nucleic acid from sample 20 the nucleic acids from which the corresponding nucleic acid reagents are used hybridize to the corresponding identifying nucleic acid fragments bound to the solid support, and the hybrids formed on the solid support are labeled with the known labeled nucleic acid fragments. 2. Sarja reagenssien yhdistelmiä, jotka on tarkoitettu käytettäväksi patenttivaatimuksen 1 mukaisessa menetelmässä, tunnettu siitä, että sarjaan kuuluu jokaista tunnistettavaksi tarkoitettua mikrobia ja/tai mikrobiryhmää kohden vähintään kaksi nukleiinihapporeagenssia, joihin 35 tarvittavat mikrobista ja/tai mikrobiryhmästä peräisin olevat kahdet erilaiset nukleiinihappofragmentit on 63596 27 valmistettu mikrobigenomin eri osista mutta edullisesti toisiaan lähellä sijaitsevista fragmenteista joko suoraan mikrobigenomista tai sinänsä tunnettua yhdistelmä-DNA-tekniikkaa hyväksi käyttäen ja nämä mikrobikohtaiset, joko 5 ryhmä- tai lajispesifiset nukleiinihappofragmentit on saatettu yksisäikeisiksi ja toinen on kiinnitetty kiinteään kantajaan ja toinen leimattu jollakin merkkiaineella.A set of reagent combinations for use in the method according to claim 1, characterized in that the set comprises at least two nucleic acid reagents for each microbe and / or microbial group to be identified, for which the two different nucleic acid fragments derived from the microbe and / or microbial group are 63596 27 prepared from different parts of the microbial genome but preferably from closely spaced fragments, either directly from the microbial genome or by recombinant DNA techniques known per se, and these microbial-specific, either group- or species-specific nucleic acid fragments are single-stranded and one is attached to a solid support and the other labeled. 3. Patenttivaatimuksen 2 mukainen sarja reagenssien yhdis-10 telmiä, tunnettu siitä, että siihen adenoviruksen tunnistamiseksi kuuluu kiinteään kantajaan sidottuna nukle-iinihapporeagenssina adenoviruksen rekombinanttiplasmidia Ad2DpOR322 ja leimattuna nukleiinihapporeagenssina adenoviruksen Ad^-BamHI C-fragmenttia. 15A series of reagent combinations according to claim 2, characterized in that it comprises, as a nucleic acid reagent bound to a solid support, the adenovirus recombinant plasmid Ad2DpOR322 as a nucleic acid reagent and the labeled adenovirus AdI-BamHI C fragment as a labeled nucleic acid reagent. 15 4. Patenttivaatimuksen 2 mukainen sarja reagenssien yhdistelmiä, tunnettu siitä, että siihen Semliki Forest -viruksen tunnistamiseksi kuuluu kiinteään kantajaan sidottuna nukleiinihapporeagenssina pKTH312-plasmidinA series of reagent combinations according to claim 2, characterized in that it comprises, as a nucleic acid reagent bound to a solid support, the plasmid pKTH312 for the identification of Semliki Forest virus. 20 EcoRI-XhoI fragmenttia A ja leimattuna nukleiinihapporeagenssina pKTH312-plasmidin EcoRI-XhoI fragmenttia B.EcoRI-XhoI fragment A and EcoRI-XhoI fragment B of plasmid pKTH312 as labeled nucleic acid reagent. 5. Patenttivaatimuksen 2 mukainen sarja reagenssien yhdistelmiä, tunnettu siitä, että SV40-viruksen tunnis- 25 tamiseksi kuuluu kiinteään kantajaan sidottuna nukleiinihapporeagenssina SV40-viruksen PstI B-fragmenttia ja leimattuna nukleiinihapporeagenssina SV40-viruksen PstI A-fragmenttia.A series of reagent combinations according to claim 2, characterized in that the PstI B fragment of SV40 virus is used as a nucleic acid reagent bound to a solid support and the PstI A fragment of SV40 virus is labeled as a labeled nucleic acid reagent. 6. Patenttivaatimuksen 2 mukainen sarja reagenssien yhdis telmiä, tunnettu siitä, että siihen Bacillus amyloliquefaciens’in tunnistamiseksi kuuluu kiinteään kantajaan sidottuna nukleiinihapporeagenssina Bacillus amyloliquefaciens' in pKTHIO plasmidissa olevan of-amylaasi-35 geenin EcoRI-BamHI-fragmenttia ja leimattuna nukleiinihapporeagenssina Bacillus amyloliquefaciens’in pKTHIO 26 63596 plasmidissa olevan CX-amylaasigeenin Clal-EcoRI-fragmenttia.A set of reagent combinations according to claim 2, characterized in that the identification of Bacillus amyloliquefaciens comprises, as a nucleic acid reagent bound to a solid support, an EcoRI-BamHIac The ClaI-EcoRI fragment of the CX amylase gene in plasmid pKTHIO 26 63596. 7. Patenttivaatimuksen 2 mukainen sarja reagenssien yhdistelmiä, tunnettu siitä, että siihen 5 Escherichia colin tunnistamiseksi kuuluu kiinteään kantajaan sidottuna nukleiinihapporeagenssina pKTH45 plasmidi ja leimattuna nukleiinihapporeagenssina yhdistelmä-faagi mKTH1207.A set of reagent combinations according to claim 2, characterized in that it comprises the plasmid pKTH45 as a nucleic acid reagent bound to a solid support for the identification of Escherichia coli and the recombinant phage mKTH1207 as a labeled nucleic acid reagent. 10 B. Patenttivaatimusten 2, 3, 5 ja 6 mukainen sarja reagenssien yhdistelmiä, tunnettu siitä, että siihen mainittujen mikrobien sekä virusten että bakteerien, kuten adenoviruksen, SV40-viruksen ja Bacillus amyloliquefaci-ens'in tunnistamiseksi ja erottamiseksi samasta näytteestä, 15 joka sisältää eri mikrobeista peräisin olevia nukleiinihappoja, kuuluu kiinteisiin kantajiin sidottuina nukleiini-happoreagensseina adenoviruksen Ad2DpBR322 rekombinantti-plasmidia, SV40-viruksen PstI B-fragmenttia sekä Bacillus amyloliquefaciens'in pKTHIO-plasmidissa olevan CX-amylaasi-20 geenin EcoRI-BamHI-fragmenttia; sekä leimattuina nukleiini-happoreagensseina adenoviruksen Ad2~BamHI C-fragmenttia, SV40-viruksen PstI A-fragmenttia sekä Bacillus amylolique-faciens'in pKTHIO plasmidissa olevaa CX-amylaasigeenin Clal-EcoRI-fragmentti a. 2'} Patentkrav 63 5 9 6B. A set of reagent combinations according to claims 2, 3, 5 and 6, characterized in that the microbes mentioned therein are capable of identifying and separating both viruses and bacteria such as adenovirus, SV40 virus and Bacillus amyloliquefaci from the same sample containing nucleic acids from various microbes include adenovirus Ad2DpBR322 recombinant plasmid, SV40 virus PstI B fragment, and the CX-amylase-20 gene of the Bacillus amyloliquefaciens plasmid pKTHIO plasmid EcoX-Bami Eco; and, as labeled nucleic acid reagents, the Ad2-BamHI C fragment of adenovirus, the PstI A fragment of SV40 virus, and the ClaI-EcoRI fragment of the CX amylase gene in the pKTHIO plasmid of Bacillus amylolique-faciens a. 2 '} Patentkrav 63 5 9 6
FI813251A 1981-10-16 1981-10-16 MICROBIA DIAGNOSIS FOERFARANDE SOM GRUNDAR SIG PAO SKIKTSHYBRIDISERING AV NUCLEINSYROR OCH VID FOERFARANDET ANVAENDA KOMBINATIONER AV REAGENSER FI63596C (en)

Priority Applications (19)

Application Number Priority Date Filing Date Title
FI813251A FI63596C (en) 1981-10-16 1981-10-16 MICROBIA DIAGNOSIS FOERFARANDE SOM GRUNDAR SIG PAO SKIKTSHYBRIDISERING AV NUCLEINSYROR OCH VID FOERFARANDET ANVAENDA KOMBINATIONER AV REAGENSER
PCT/FI1982/000038 WO1983001459A1 (en) 1981-10-16 1982-09-29 A method and reagent combination for the diagnosis of microorganisms by sandwich hybridization of nucleic acids
EP82902982A EP0098267A1 (en) 1981-10-16 1982-09-29 A method and reagent combination for the diagnosis of microorganisms by sandwich hybridization of nucleic acids
AU89575/82A AU548854B2 (en) 1981-10-16 1982-09-29 A method and reagent combination for the diagnosis of microorganisms
JP57502956A JPS58501703A (en) 1981-10-16 1982-09-29 Combination of microbial identification methods and microbial identification reagents
HU823529A HU196242B (en) 1981-10-16 1982-09-29 Process and reagent combination for identifying microorganisms by sandwich-hybridization of nucleic acids
JP57-502956A JPH0632637B2 (en) 1981-10-16 1982-09-29 Combination of microbial identification method and microbial identification reagent
FI823452A FI823452A0 (en) 1981-10-16 1982-10-11 FOERFARANDE FOER STABILIZERING AV I NUCLEINSYREHYBRIDISERING ANVAENDA FILTER
US06/434,182 US4486539A (en) 1981-10-16 1982-10-14 Detection of microbial nucleic acids by a one-step sandwich hybridization test
DE8282305489T DE3277917D1 (en) 1981-10-16 1982-10-15 A method and reagent combination for the identification of microorganisms and the use of sandwich hybridization of nucleic acids therefor
DE198282305489T DE79139T1 (en) 1981-10-16 1982-10-15 METHOD AND REAGENT COMBINATION FOR THE IDENTIFICATION OF MICROORGANISMS AND THE APPLICATION OF SANDWICH HYBRIDIZATION OF NUCLEIC ACIDS FOR THIS.
EP82305489A EP0079139B1 (en) 1981-10-16 1982-10-15 A method and reagent combination for the identification of microorganisms and the use of sandwich hybridization of nucleic acids therefor
AT82305489T ATE31735T1 (en) 1981-10-16 1982-10-15 METHOD AND REAGENT COMBINATION FOR THE IDENTIFICATION OF MICROORGANISMS AND THE APPLICATION OF SANDWICH HYBRIDIZATION OF NUCLEIC ACIDS THEREFOR.
CA000413539A CA1192120A (en) 1981-10-16 1982-10-15 Method and reagent combination for the diagnosis of microorganisms
NO83832061A NO163699C (en) 1981-10-16 1983-06-07 PROCEDURE AND REAGENT COMBINATION FOR DIAGNOSIS OF MICROORGANISMS.
DK198302751A DK173744B1 (en) 1981-10-16 1983-06-15 Method and reagent combination for diagnosis of microorganisms
SU833663405A SU1386031A3 (en) 1981-10-16 1983-11-15 Method of identifying viruses and bacteria
RO112563A RO86356B (en) 1981-10-16 1983-11-15 Microbial identification method
US06/566,532 US4563419A (en) 1981-10-16 1983-12-29 Detection of microbial nucleic acids by a one-step sandwich hybridization test

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI813251 1981-10-16
FI813251A FI63596C (en) 1981-10-16 1981-10-16 MICROBIA DIAGNOSIS FOERFARANDE SOM GRUNDAR SIG PAO SKIKTSHYBRIDISERING AV NUCLEINSYROR OCH VID FOERFARANDET ANVAENDA KOMBINATIONER AV REAGENSER

Publications (2)

Publication Number Publication Date
FI63596B FI63596B (en) 1983-03-31
FI63596C true FI63596C (en) 1983-07-11

Family

ID=8514776

Family Applications (1)

Application Number Title Priority Date Filing Date
FI813251A FI63596C (en) 1981-10-16 1981-10-16 MICROBIA DIAGNOSIS FOERFARANDE SOM GRUNDAR SIG PAO SKIKTSHYBRIDISERING AV NUCLEINSYROR OCH VID FOERFARANDET ANVAENDA KOMBINATIONER AV REAGENSER

Country Status (13)

Country Link
US (2) US4486539A (en)
EP (2) EP0098267A1 (en)
JP (2) JPH0632637B2 (en)
AT (1) ATE31735T1 (en)
AU (1) AU548854B2 (en)
CA (1) CA1192120A (en)
DE (2) DE3277917D1 (en)
DK (1) DK173744B1 (en)
FI (1) FI63596C (en)
HU (1) HU196242B (en)
RO (1) RO86356B (en)
SU (1) SU1386031A3 (en)
WO (1) WO1983001459A1 (en)

Families Citing this family (342)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI63596C (en) * 1981-10-16 1983-07-11 Orion Yhtymae Oy MICROBIA DIAGNOSIS FOERFARANDE SOM GRUNDAR SIG PAO SKIKTSHYBRIDISERING AV NUCLEINSYROR OCH VID FOERFARANDET ANVAENDA KOMBINATIONER AV REAGENSER
US5612183A (en) * 1983-01-10 1997-03-18 Gen-Probe Incorporated Method for determining the effect of antimicrobial agents on growth using ribosomal nucleic acid subunit subsequence specific probes
US5723597A (en) * 1983-01-10 1998-03-03 Gen-Probe Incorporated Ribosomal nucleic acid probes for detecting organisms or groups of organisms
US5288611A (en) * 1983-01-10 1994-02-22 Gen-Probe Incorporated Method for detecting, identifying, and quantitating organisms and viruses
US4689295A (en) * 1983-01-20 1987-08-25 Integrated Genetics, Inc. Test for Salmonella
US4994373A (en) 1983-01-27 1991-02-19 Enzo Biochem, Inc. Method and structures employing chemically-labelled polynucleotide probes
US4948882A (en) * 1983-02-22 1990-08-14 Syngene, Inc. Single-stranded labelled oligonucleotides, reactive monomers and methods of synthesis
WO1984003285A1 (en) * 1983-02-22 1984-08-30 Molecular Biosystems Inc Defined sequence single strand oligonucleotides incorporating reporter groups, process for the chemical synthesis thereof, and nucleosides useful in such synthesis
US5593832A (en) * 1983-02-28 1997-01-14 Lifecodes Corporation Method for forensic analysis
IL71064A (en) * 1983-02-28 1989-10-31 Lifecodes Corp Paternity and forensic test involving analysis of dna polymorphic genetic regions
CA1228811A (en) 1983-05-05 1987-11-03 Robert G. Pergolizzi Assay method utilizing polynucleotide sequences
CA1222680A (en) * 1983-07-05 1987-06-09 Nanibhushan Dattagupta Testing dna samples for particular nucleotide sequences
US4737454A (en) * 1983-07-14 1988-04-12 Molecular Diagnostics, Inc. Fast photochemical method of labelling nucleic acids for detection purposes in hybridization assays
US4959309A (en) * 1983-07-14 1990-09-25 Molecular Diagnostics, Inc. Fast photochemical method of labelling nucleic acids for detection purposes in hybridization assays
CA1231303A (en) * 1983-08-05 1988-01-12 Robert J. Carrico Detection of bacteria by nucleic acid hybridization
US5539097A (en) * 1983-09-02 1996-07-23 Molecular Biosystems, Inc. Oligonucleotide polymeric support system
JPS6091999A (en) * 1983-10-25 1985-05-23 Fujirebio Inc Measurement of polynucleotide
GB8331071D0 (en) * 1983-11-22 1983-12-29 Karayiannis P Assay for dna/rna
US4724202A (en) * 1983-12-12 1988-02-09 Molecular Diagnostics, Inc. Use of non-hybridizable nucleic acids for the detection of nucleic acid hybridization
US4777129A (en) * 1983-12-12 1988-10-11 Molecular Diagnostics, Inc. Nucleic acid probe detectable by specific nucleic acid binding protein
IL73577A (en) * 1983-12-12 1989-10-31 Miles Lab Method and reagent system for detecting dna or rna sequences in a test medium containing single stranded dna or rna using antibodies to intercalation complexes with double stranded nucleic acid
US4849505A (en) * 1984-01-30 1989-07-18 Enzo Biochem, Inc. Detectable molecules, method of preparation and use
US4943523A (en) * 1984-01-30 1990-07-24 Enzo Biochem, Inc. Detectable molecules, method of preparation and use
US4849208A (en) * 1984-01-30 1989-07-18 Enzo Biochem, Inc. Detectable molecules, method of preparation and use
US5002885A (en) * 1984-01-30 1991-03-26 Enzo Biochem, Inc. Detectable molecules, method preparation and use
US4843122A (en) * 1984-01-30 1989-06-27 Enzo Biochem, Inc. Detectable molecules, method of preparation and use
US4707440A (en) * 1984-01-30 1987-11-17 Enzo Biochem, Inc. Nucleic acid hybridization assay and detectable molecules useful in such assay
FI71768C (en) * 1984-02-17 1987-02-09 Orion Yhtymae Oy FOERBAETTRADE NYKLEINSYRAREAGENSER OCH FOERFARANDE FOER DERAS FRAMSTAELLNING.
CA1223222A (en) * 1984-02-22 1987-06-23 Nanibhushan Dattagupta Immobilized nucleic acid-containing probes
JPH06100605B2 (en) * 1984-04-05 1994-12-12 ハワ−ド フロ−リ インステイチユ−ト オブ イクスペリメンタル フイジオロジ アンド メデイスン Hybridization histochemistry
US6221581B1 (en) * 1984-04-27 2001-04-24 Enzo Diagnostics, Inc. Processes for detecting polynucleotides, determining genetic mutations or defects in genetic material, separating or isolating nucleic acid of interest from samples, and useful compositions of matter and multihybrid complex compositions
US5288609A (en) * 1984-04-27 1994-02-22 Enzo Diagnostics, Inc. Capture sandwich hybridization method and composition
CA1260372A (en) * 1984-04-27 1989-09-26 Elazar Rabbani Hybridization method for the detection of genetic materials
US4766062A (en) * 1984-05-07 1988-08-23 Allied Corporation Displacement polynucleotide assay method and polynucleotide complex reagent therefor
US4766064A (en) * 1984-05-07 1988-08-23 Allied Corporation Displacement polynucleotide assay employing polyether and diagnostic kit
US4670380A (en) * 1984-05-23 1987-06-02 Molecular Diagnostics, Inc. Assays utilizing labeled nucleic acid probes
US5132206A (en) * 1984-06-11 1992-07-21 Dreyer William J Fluorescent pigments for tagging biological molecules
US4749647A (en) * 1984-06-22 1988-06-07 Genetic Systems Corporation Polymerization-induced separation assay using recognition pairs
FR2567541B1 (en) * 1984-07-13 1987-02-06 Pasteur Institut DNA PROBE AND METHOD FOR THE DETECTION OF "SHIGELLES" AND ENTERO-INVASIVE STRAINS OF ESCHERICHIA COLI
US4755458A (en) * 1984-08-30 1988-07-05 Enzo Biochem, Inc. Composition and method for the detection of the presence of a polynucleotide sequence of interest
US4563417A (en) * 1984-08-31 1986-01-07 Miles Laboratories, Inc. Nucleic acid hybridization assay employing antibodies to intercalation complexes
US5955261A (en) * 1984-09-04 1999-09-21 Gen-Probe Incorporated Method for detecting the presence of group-specific viral mRNA in a sample
US5430136A (en) * 1984-10-16 1995-07-04 Chiron Corporation Oligonucleotides having selectably cleavable and/or abasic sites
US4775619A (en) * 1984-10-16 1988-10-04 Chiron Corporation Polynucleotide determination with selectable cleavage sites
US4820630A (en) * 1984-11-23 1989-04-11 Digene Diagnostics, Incorporated Assay for nucleic acid sequences, particularly genetic lesions, using interactive labels
US4734363A (en) * 1984-11-27 1988-03-29 Molecular Diagnostics, Inc. Large scale production of DNA probes
US5242794A (en) * 1984-12-13 1993-09-07 Applied Biosystems, Inc. Detection of specific sequences in nucleic acids
US4883750A (en) * 1984-12-13 1989-11-28 Applied Biosystems, Inc. Detection of specific sequences in nucleic acids
GB8432118D0 (en) * 1984-12-19 1985-01-30 Malcolm A D B Sandwich hybridisation technique
GB2179448B (en) * 1984-12-19 1989-06-07 Blair Malcolm A D Improved sandwich hybridisation technique for the detection of nucleotide sequences
US4670379A (en) * 1984-12-19 1987-06-02 E. I. Du Pont De Nemours And Company Polynucleotide hydridization assays employing catalyzed luminescence
FI72146C (en) * 1985-01-02 1987-04-13 Orion Yhtymae Oy Procedure for Identifying Nucleic Acids.
US4785086A (en) * 1985-01-17 1988-11-15 Integrated Genetics, Inc. Test for Campylobacter
US5851767A (en) * 1985-03-04 1998-12-22 The Regents Of The University Of California Detection of prokaryotic organism by DNA hybridization
US4792519A (en) * 1985-03-05 1988-12-20 International Technology Corporation Method for the monitoring and control of microbial populations
US5217866A (en) * 1985-03-15 1993-06-08 Anti-Gene Development Group Polynucleotide assay reagent and method
US5470974A (en) * 1985-03-15 1995-11-28 Neu-Gene Development Group Uncharged polynucleotide-binding polymers
US6040166A (en) * 1985-03-28 2000-03-21 Roche Molecular Systems, Inc. Kits for amplifying and detecting nucleic acid sequences, including a probe
US6197563B1 (en) 1985-03-28 2001-03-06 Roche Molecular Systems, Inc. Kits for amplifying and detecting nucleic acid sequences
EP0200113A3 (en) * 1985-04-30 1987-03-18 Pandex Laboratories, Inc. A method of solid phase nucleic acid hybridization assay incorporating a luminescent label
US5273882A (en) * 1985-06-13 1993-12-28 Amgen Method and kit for performing nucleic acid hybridization assays
US4751177A (en) * 1985-06-13 1988-06-14 Amgen Methods and kits for performing nucleic acid hybridization assays
IL79112A (en) * 1985-06-13 1992-01-15 Abbott Lab Method for the isolation of a nucleic acid sequence and kit for performing a hybridization assay
US5641630A (en) * 1985-06-13 1997-06-24 Amgen Inc. Method and kit for performing nucleic acid hybridization assays
AU558846B2 (en) * 1985-06-21 1987-02-12 Miles Laboratories Inc. Solid-phase hydridization assay using anti-hybrid antibodies
US4831125A (en) * 1985-07-01 1989-05-16 E. I. Du Pont De Nemours And Company DNA probe for corynebacterium kutscheri
US4824776A (en) * 1985-07-25 1989-04-25 Molecular Biosystems, Inc. Method for increasing the sensitivity of nucleic acid hybridization assays
US5155216A (en) * 1985-08-15 1992-10-13 Amoco Corporation Nucleic acids labeled with a chemiluminescent acridine ester
US4868104A (en) * 1985-09-06 1989-09-19 Syntex (U.S.A.) Inc. Homogeneous assay for specific polynucleotides
US5595908A (en) * 1985-09-26 1997-01-21 University Of Southern Mississipi Piezoelectric device for detection of polynucleotide hybridization
EP0244471A4 (en) * 1985-10-24 1988-01-28 Siska Diagnostics Inc Lanthanide chelate-tagged nucleic acid probes.
US5258283A (en) * 1985-11-05 1993-11-02 Battelle Memorial Institute Detection and differentiation of coxiella burnetii in biological fluids
US4876186A (en) * 1985-11-05 1989-10-24 Battelle Development Corporation Detection and differentiation of coxiella burnetii in biological fluids
JPS63502477A (en) * 1985-12-03 1988-09-22 エル・ギユ−リイ・エム・ラフアツト Methods, devices and products for disease diagnosis
US4910300A (en) * 1985-12-11 1990-03-20 Chiron Corporation Method for making nucleic acid probes
US4868105A (en) * 1985-12-11 1989-09-19 Chiron Corporation Solution phase nucleic acid sandwich assay
US4882269A (en) * 1985-12-13 1989-11-21 Princeton University Amplified hybridization assay
JP3293820B2 (en) * 1985-12-13 2002-06-17 エンゾ− バイオケム インコ−ポレイテツド Novel one-step method and polynucleotide compound for hybridizing to target polynucleotide
FI76119C (en) * 1986-02-27 1988-09-09 Orion Yhtymae Oy QUANTITATIVE BEARING OF NUCLEIN SYRAMOLEKYLER AND REAGENTS FOERPACKNING SOM ANVAENDS VID FOERFARANDET.
US4968602A (en) * 1986-03-05 1990-11-06 Molecular Diagnostics, Inc. Solution-phase single hybridization assay for detecting polynucleotide sequences
US5242823A (en) * 1986-03-07 1993-09-07 International Genetic Engineering, Inc. Cloning of the 38kd Mycoplasma hyorhinis regression-associated antigen
US4925785A (en) * 1986-03-07 1990-05-15 Biotechnica Diagnostics, Inc. Nucleic acid hybridization assays
EP0250662B1 (en) * 1986-06-25 1994-08-24 The Regents Of The University Of California Detection of mycoplasma by DNA hybridization
JP2534529B2 (en) * 1986-07-24 1996-09-18 ブリティシュ・テレコミュニケ−ションズ・パブリック・リミテッド・カンパニ Radiation generator
EP0276302B1 (en) * 1986-08-11 1993-04-28 Siska Diagnostics,Inc. Nucleic acid probe assay methods and compositions
US5849478A (en) * 1986-08-14 1998-12-15 Cashman; Daniel P. Blocked-polymerase polynucleotide immunoassay method and kit
US4917999A (en) * 1986-09-02 1990-04-17 Miles Inc. Oligonucleotide probes for detection of α-amylase genes
US5714380A (en) 1986-10-23 1998-02-03 Amoco Corporation Closed vessel for isolating target molecules and for performing amplification
US7087742B1 (en) 1986-11-24 2006-08-08 Gen-Probe Incorporated Oligonucleotide probes for the detection and/or quantitation of non-viral organisms
US5994059A (en) * 1986-11-24 1999-11-30 Gen-Probe Incorporated Nucleic acid probes and methods for detecting Streptomyces enterococci
US6150517A (en) * 1986-11-24 2000-11-21 Gen-Probe Methods for making oligonucleotide probes for the detection and/or quantitation of non-viral organisms
US7138516B1 (en) 1986-11-24 2006-11-21 Gen-Probe Incorporated Oligonucleotide probes for the detection and/or quantitation of non-viral organisms
US5541308A (en) * 1986-11-24 1996-07-30 Gen-Probe Incorporated Nucleic acid probes for detection and/or quantitation of non-viral organisms
US4994372A (en) * 1987-01-14 1991-02-19 President And Fellows Of Harvard College DNA sequencing
US4795699A (en) * 1987-01-14 1989-01-03 President And Fellows Of Harvard College T7 DNA polymerase
US5266466A (en) * 1987-01-14 1993-11-30 President And Fellows Of Harvard College Method of using T7 DNA polymerase to label the 3' end of a DNA molecule
US5145776A (en) * 1987-01-14 1992-09-08 President & Fellows Of Harvard College Method of using T7 DNA polymerase to mutagenize and fill-in DNA
US4942130A (en) * 1987-01-14 1990-07-17 President & Fellows Of Harvard College T7 DNA polymerase
US4946786A (en) * 1987-01-14 1990-08-07 President And Fellows Of Harvard College T7 DNA polymerase
US5599667A (en) * 1987-03-02 1997-02-04 Gen-Probe Incorporated Polycationic supports and nucleic acid purification separation and hybridization
AU622104B2 (en) * 1987-03-11 1992-04-02 Sangtec Molecular Diagnostics Ab Method of assaying of nucleic acids, a reagent combination and kit therefore
CA1317860C (en) * 1987-04-01 1993-05-18 Daniel Louis Kacian Techniques for preparing specimens for bacterial assays
US6270961B1 (en) * 1987-04-01 2001-08-07 Hyseq, Inc. Methods and apparatus for DNA sequencing and DNA identification
GB8709803D0 (en) * 1987-04-24 1987-05-28 Mcfadden J J Treatment of crohn's disease &c
US5225324A (en) * 1987-04-24 1993-07-06 Bioscience International, Inc. Diagnostics for mycobacteria in public health, medical, and veterinary practice
US5273879A (en) * 1987-07-23 1993-12-28 Syntex (U.S.A.) Inc. Amplification method for polynucleotide assays
US4994368A (en) * 1987-07-23 1991-02-19 Syntex (U.S.A.) Inc. Amplification method for polynucleotide assays
AU623090B2 (en) * 1987-07-31 1992-05-07 Gen-Probe Incorporated Assay for polynucleotides employing oligonucleotides to eliminate undesirable cross reactions
US5089386A (en) * 1987-09-11 1992-02-18 Gene-Trak Systems Test for listeria
US5656731A (en) * 1987-10-15 1997-08-12 Chiron Corporation Nucleic acid-amplified immunoassay probes
US5359100A (en) * 1987-10-15 1994-10-25 Chiron Corporation Bifunctional blocked phosphoramidites useful in making nucleic acid mutimers
AU2714988A (en) * 1987-10-23 1989-06-01 Siska Diagnostics, Inc. Lanthanide chelate-tagged nucleic acid probes
US6013531A (en) * 1987-10-26 2000-01-11 Dade International Inc. Method to use fluorescent magnetic polymer particles as markers in an immunoassay
CA1340506C (en) * 1987-11-24 1999-04-20 Nicholas H. Carbonetti Production of gonorrheal pi proteins and vaccines
US6348332B1 (en) 1987-11-24 2002-02-19 The University Of North Carolina At Chapel Hill DNA molecule encoding gonorrhoeal hybrid PIA/PIB protein
DE3854943T2 (en) * 1987-12-01 1996-09-05 Amoco Corp DETECTION OF SALMONELLA
US5354657A (en) * 1988-01-12 1994-10-11 Boehringer Mannheim Gmbh Process for the highly specific detection of nucleic acids in solid
US20050019760A1 (en) * 1988-03-05 2005-01-27 Oxford Gene Technology Limited Analysing polynucleotide sequences
GB8810400D0 (en) 1988-05-03 1988-06-08 Southern E Analysing polynucleotide sequences
US7811751B2 (en) 1988-05-03 2010-10-12 Oxford Gene Technology Limited Analysing polynucleotide sequences
US5700637A (en) * 1988-05-03 1997-12-23 Isis Innovation Limited Apparatus and method for analyzing polynucleotide sequences and method of generating oligonucleotide arrays
US6054270A (en) * 1988-05-03 2000-04-25 Oxford Gene Technology Limited Analying polynucleotide sequences
WO1989010979A1 (en) * 1988-05-10 1989-11-16 E.I. Du Pont De Nemours And Company Process for rapid nucleic acid detection
US5024933A (en) * 1988-05-10 1991-06-18 Enzo Biochem, Inc. Method and kit for sample adherence to test substrate
US5294533A (en) * 1988-07-05 1994-03-15 Baylor College Of Medicine Antisense oligonucleotide antibiotics complementary to the macromolecular synthesis operon, methods of treating bacterial infections and methods for identification of bacteria
US5047523A (en) * 1988-08-02 1991-09-10 Ortho Diagnostic Systems Inc. Nucleic acid probe for detection of neisseria gonorrhoea
US5185243A (en) * 1988-08-25 1993-02-09 Syntex (U.S.A.) Inc. Method for detection of specific nucleic acid sequences
WO1990006372A1 (en) * 1988-12-01 1990-06-14 Microprobe Corporation Substrates for peroxidase assaying
US7172863B1 (en) 1988-12-09 2007-02-06 Gen-Probe Incorporated Nucleic acid probes and methods for detecting Neisseria gonorrhoeae
US5324829A (en) * 1988-12-16 1994-06-28 Ortho Diagnostic Systems, Inc. High specific activity nucleic acid probes having target recognition and signal generating moieties
GR1000347B (en) * 1988-12-21 1992-06-25 Ortho Diagnostic Systems Inc Method of preparing nucleotide probes using a bridging complement
US5237016A (en) * 1989-01-05 1993-08-17 Siska Diagnostics, Inc. End-attachment of oligonucleotides to polyacrylamide solid supports for capture and detection of nucleic acids
US5514550A (en) * 1989-02-03 1996-05-07 Johnson & Johnson Clinical Diagnostics, Inc. Nucleic acid test article and its use to detect a predetermined nucleic acid
CA2009708A1 (en) * 1989-02-13 1990-08-13 Jane D. Madonna Nucleic acid probe for the detection of salmonella human pathogens
US5856092A (en) * 1989-02-13 1999-01-05 Geneco Pty Ltd Detection of a nucleic acid sequence or a change therein
US5049489A (en) * 1989-04-17 1991-09-17 The Standard Oil Company 16S rRNA oligonucleotide probes for the identification of sulfate-reducing bacteria
US5143854A (en) * 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
US6040138A (en) 1995-09-15 2000-03-21 Affymetrix, Inc. Expression monitoring by hybridization to high density oligonucleotide arrays
US5800992A (en) * 1989-06-07 1998-09-01 Fodor; Stephen P.A. Method of detecting nucleic acids
US6919211B1 (en) 1989-06-07 2005-07-19 Affymetrix, Inc. Polypeptide arrays
US6379895B1 (en) 1989-06-07 2002-04-30 Affymetrix, Inc. Photolithographic and other means for manufacturing arrays
US5925525A (en) * 1989-06-07 1999-07-20 Affymetrix, Inc. Method of identifying nucleotide differences
US6551784B2 (en) 1989-06-07 2003-04-22 Affymetrix Inc Method of comparing nucleic acid sequences
US6955915B2 (en) * 1989-06-07 2005-10-18 Affymetrix, Inc. Apparatus comprising polymers
US5744101A (en) 1989-06-07 1998-04-28 Affymax Technologies N.V. Photolabile nucleoside protecting groups
EP0405592A3 (en) * 1989-06-30 1991-07-17 Sanyo Chemical Industries Ltd. A method for detection of nucleic acid and reagents for their detection
US5106730A (en) * 1989-07-24 1992-04-21 Microprobe Corporation Lactam-containing compositions and methods useful for the hybridization of nucleic acids
US5232829A (en) * 1989-09-29 1993-08-03 Hoffmann-La Roche Inc. Detection of chlamydia trachomatis by polymerase chain reaction using biotin labelled lina primers and capture probes
CA2028012A1 (en) * 1989-10-23 1991-04-24 Randall Dimond Hybridization assay for campylobacter rrna
GB8924989D0 (en) * 1989-11-06 1989-12-28 Scotgen Ltd Method and device for the detection of antibiotic resistance
ATE148746T1 (en) * 1989-12-14 1997-02-15 Dade Int Inc MAGNETIC AND FLUORESCENT POLYMER PARTICLES AND THEIR APPLICATION
CA2032203C (en) * 1989-12-29 2009-05-19 Christine L. Brakel Amplification capture assay
CA2075186A1 (en) * 1990-02-02 1991-08-03 Rudi Rossau Hybridization probes for the detection of branhamella catarrhalis strains
US5721097A (en) * 1990-02-02 1998-02-24 N. V. Innogenetics S.A. Hybridization probes for the detection of branhamella catarrhalis strains
US6013431A (en) * 1990-02-16 2000-01-11 Molecular Tool, Inc. Method for determining specific nucleotide variations by primer extension in the presence of mixture of labeled nucleotides and terminators
US5200314A (en) * 1990-03-23 1993-04-06 Chiron Corporation Polynucleotide capture assay employing in vitro amplification
AU7429591A (en) * 1990-04-18 1991-10-24 Gene-Trak Systems Nucleic acid probes for the detection of giardia lamblia
AU659798B2 (en) * 1990-05-04 1995-06-01 Chiron Corporation Protein-nucleic acid probes and immunoassays using same
US5670316A (en) * 1990-05-07 1997-09-23 Daikin Industries, Ltd. Diagnostic applications of double D-loop formation
US5232830A (en) * 1990-05-11 1993-08-03 Microprobe Corporation Intrinsic fluorescent quenching methods
US5695926A (en) * 1990-06-11 1997-12-09 Bio Merieux Sandwich hybridization assays using very short capture probes noncovalently bound to a hydrophobic support
NZ239084A (en) * 1990-07-24 1994-09-27 Uab Research Foundation Bovine respiratory virus (brs) f glycoprotein and vaccine therefrom
US6730305B1 (en) 2000-05-08 2004-05-04 The Uab Research Foundation Nucleotide sequences encoding bovine respiratory syncytial virus immunogenic proteins
IL99025A0 (en) * 1990-08-15 1992-07-15 Astra Ab Novel process for the detection of pathogens using dna probes
WO1992008808A1 (en) * 1990-11-14 1992-05-29 Siska Diagnostics, Inc. Non-isotopic detection of nucleic acids using a polystyrene support-based sandwich hybridization assay and compositions useful therefor
AU1248292A (en) * 1990-12-06 1992-07-08 Affymax Technologies N.V. Sequencing by hybridization of a target nucleic acid to a matrix of defined oligonucleotides
USH1398H (en) * 1990-12-28 1995-01-03 Campbell; James R. DNA-based fluourescent sensor
EP0497464A1 (en) * 1991-01-31 1992-08-05 Amoco Corporation Rapid microbial diagnostics by in situ hybridization in aqueous suspension
ES2108109T3 (en) * 1991-02-14 1997-12-16 Dade Microscan Inc NEW OLIGONUCLEOTIDES CONJUGATED WITH LANTANIDES CHELATES.
US6004744A (en) 1991-03-05 1999-12-21 Molecular Tool, Inc. Method for determining nucleotide identity through extension of immobilized primer
WO1992018647A1 (en) * 1991-04-15 1992-10-29 Sumitomo Electric Industries, Ltd. Process for separating or extracting nucleic acid from specimen containing the same
US5556748A (en) * 1991-07-30 1996-09-17 Xenopore Corporation Methods of sandwich hybridization for the quantitative analysis of oligonucleotides
US5612199A (en) * 1991-10-11 1997-03-18 Behringwerke Ag Method for producing a polynucleotide for use in single primer amplification
DK0549107T3 (en) 1991-10-11 1998-08-31 Dade Behring Marburg Gmbh Process for Preparing a Polynucleotide for Use in Single Primer Amplification and Phosphorothioate-Containing Oils
US5849486A (en) * 1993-11-01 1998-12-15 Nanogen, Inc. Methods for hybridization analysis utilizing electrically controlled hybridization
US6652808B1 (en) * 1991-11-07 2003-11-25 Nanotronics, Inc. Methods for the electronic assembly and fabrication of devices
US6017696A (en) * 1993-11-01 2000-01-25 Nanogen, Inc. Methods for electronic stringency control for molecular biological analysis and diagnostics
US5632957A (en) 1993-11-01 1997-05-27 Nanogen Molecular biological diagnostic systems including electrodes
US6051380A (en) * 1993-11-01 2000-04-18 Nanogen, Inc. Methods and procedures for molecular biological analysis and diagnostics
US5605662A (en) 1993-11-01 1997-02-25 Nanogen, Inc. Active programmable electronic devices for molecular biological analysis and diagnostics
US6048690A (en) * 1991-11-07 2000-04-11 Nanogen, Inc. Methods for electronic fluorescent perturbation for analysis and electronic perturbation catalysis for synthesis
US6569382B1 (en) 1991-11-07 2003-05-27 Nanogen, Inc. Methods apparatus for the electronic, homogeneous assembly and fabrication of devices
ES2049618B1 (en) * 1991-11-13 1994-11-01 Consejo Superior Investigacion DIAGNOSTIC METHOD AND CLASSIFICATION OF TRYPANOSOMA CRUZI SPECIES.
WO1993020234A1 (en) * 1992-03-31 1993-10-14 E.I. Du Pont De Nemours And Company A rapid, high capacity nucleic acid based assay
US6100099A (en) 1994-09-06 2000-08-08 Abbott Laboratories Test strip having a diagonal array of capture spots
DE4212555A1 (en) * 1992-04-15 1993-10-21 Boehringer Mannheim Gmbh Methods for the detection of nucleic acids
US5543292A (en) * 1992-06-16 1996-08-06 Hitachi, Ltd. Process for the measurement of nucleic acids
WO1994003637A1 (en) * 1992-07-31 1994-02-17 Syntex (Usa) Inc. Method for introducing defined sequences at the 3' end of polynucleotides
US7713528B1 (en) 1993-02-18 2010-05-11 Enzo Therapeutics, Inc. Method for in vivo delivery of active compounds using reagent conjugate
US6294323B1 (en) 1993-04-14 2001-09-25 Behringwerke Ag Self initiating single primer amplification of nucleic acids
CA2163249A1 (en) * 1993-05-28 1994-12-08 Henri Tiedge Bc200 rna, probes therefor and use thereof
DE4344742A1 (en) * 1993-06-09 1994-12-15 Boehringer Mannheim Gmbh Method for the immobilization of nucleic acids
US5532122A (en) * 1993-10-12 1996-07-02 Biotraces, Inc. Quantitation of gamma and x-ray emitting isotopes
US5854084A (en) 1996-07-12 1998-12-29 Biotraces, Inc. Enhanced chromatography using multiphoton detection
US6638482B1 (en) 1993-11-01 2003-10-28 Nanogen, Inc. Reconfigurable detection and analysis apparatus and method
US7101661B1 (en) 1993-11-01 2006-09-05 Nanogen, Inc. Apparatus for active programmable matrix devices
US6254827B1 (en) 1993-11-01 2001-07-03 Nanogen, Inc. Methods for fabricating multi-component devices for molecular biological analysis and diagnostics
US6375899B1 (en) 1993-11-01 2002-04-23 Nanogen, Inc. Electrophoretic buss for transport of charged materials in a multi-chamber system
US6225059B1 (en) 1993-11-01 2001-05-01 Nanogen, Inc. Advanced active electronic devices including collection electrodes for molecular biological analysis and diagnostics
US6331274B1 (en) 1993-11-01 2001-12-18 Nanogen, Inc. Advanced active circuits and devices for molecular biological analysis and diagnostics
US7314708B1 (en) 1998-08-04 2008-01-01 Nanogen, Inc. Method and apparatus for electronic synthesis of molecular structures
US20040077074A1 (en) * 1993-11-01 2004-04-22 Nanogen, Inc. Multi-chambered analysis device
US6315953B1 (en) * 1993-11-01 2001-11-13 Nanogen, Inc. Devices for molecular biological analysis and diagnostics including waveguides
US6726880B1 (en) 1993-11-01 2004-04-27 Nanogen, Inc. Electronic device for performing active biological operations and method of using same
US7582421B2 (en) * 1993-11-01 2009-09-01 Nanogen, Inc. Methods for determination of single nucleic acid polymorphisms using a bioelectronic microchip
US6309602B1 (en) 1993-11-01 2001-10-30 Nanogen, Inc. Stacked, reconfigurable system for electrophoretic transport of charged materials
US7172864B1 (en) 1993-11-01 2007-02-06 Nanogen Methods for electronically-controlled enzymatic reactions
US6068818A (en) * 1993-11-01 2000-05-30 Nanogen, Inc. Multicomponent devices for molecular biological analysis and diagnostics
US6287517B1 (en) 1993-11-01 2001-09-11 Nanogen, Inc. Laminated assembly for active bioelectronic devices
US6319472B1 (en) 1993-11-01 2001-11-20 Nanogen, Inc. System including functionally separated regions in electrophoretic system
CA2176496C (en) * 1993-11-29 1999-09-28 Kathleen A. Clark Method for extracting nucleic acids from a wide range of organisms
BR9507343A (en) * 1994-04-04 1997-09-16 Ciba Corning Diagnostics Corp Hybridization tests - binding for the detection of specific nucleic acid sequences
US5807522A (en) * 1994-06-17 1998-09-15 The Board Of Trustees Of The Leland Stanford Junior University Methods for fabricating microarrays of biological samples
US7378236B1 (en) 1994-06-17 2008-05-27 The Board Of Trustees Of The Leland Stanford Junior University Method for analyzing gene expression patterns
US7323298B1 (en) * 1994-06-17 2008-01-29 The Board Of Trustees Of The Leland Stanford Junior University Microarray for determining the relative abundances of polynuceotide sequences
US6379897B1 (en) * 2000-11-09 2002-04-30 Nanogen, Inc. Methods for gene expression monitoring on electronic microarrays
US7857957B2 (en) * 1994-07-07 2010-12-28 Gamida For Life B.V. Integrated portable biological detection system
US6403367B1 (en) * 1994-07-07 2002-06-11 Nanogen, Inc. Integrated portable biological detection system
US5545527A (en) 1994-07-08 1996-08-13 Visible Genetics Inc. Method for testing for mutations in DNA from a patient sample
US8236493B2 (en) 1994-10-21 2012-08-07 Affymetrix, Inc. Methods of enzymatic discrimination enhancement and surface-bound double-stranded DNA
CA2163393C (en) * 1994-11-30 2003-04-22 Colleen Marie Nycz Amplification and detection of mycobacteria nucleic acids
US5783387A (en) * 1995-02-06 1998-07-21 The Regents Of The University Of California Method for identifying and quantifying nucleic acid sequence aberrations
US5731153A (en) * 1996-08-26 1998-03-24 The Regents Of The University Of California Identification of random nucleic acid sequence aberrations using dual capture probes which hybridize to different chromosome regions
US5610023A (en) * 1995-03-31 1997-03-11 Lee Laboratories, Inc. Method of purification of clostridium difficile toxin A and production of mono-specific antibodies
US5783453A (en) * 1995-06-29 1998-07-21 Chiron Diagnostics Corporation Non-separation specific binding chemiluminescent assay
US6027879A (en) * 1995-08-09 2000-02-22 The Regents Of The University Of California Detection and isolation of nucleic acid sequences using a bifunctional hybridization probe
US5616465A (en) 1995-08-09 1997-04-01 The Regents Of The University Of California Detection and isolation of nucleic acid sequences using competitive hybridization probes
US5770365A (en) * 1995-08-25 1998-06-23 Tm Technologies, Inc. Nucleic acid capture moieties
US20040086917A1 (en) * 1995-09-27 2004-05-06 Nanogen, Inc. Methods for electronic fluorescent perturbation for analysis and electronic perturbation catalysis for synthesis
EP0880598A4 (en) 1996-01-23 2005-02-23 Affymetrix Inc Nucleic acid analysis techniques
AU2320597A (en) 1996-03-19 1997-10-10 Molecular Tool, Inc. Method for determining the nucleotide sequence of a polynucleotide
US5814490A (en) * 1996-06-11 1998-09-29 Becton, Dickinson And Company Amplification and detection of chlamydia trachomatis nucleic acids
US5910410A (en) * 1996-09-06 1999-06-08 Hewlett-Packard Company Dual tag binding assay
US5853993A (en) * 1996-10-21 1998-12-29 Hewlett-Packard Company Signal enhancement method and kit
US6706473B1 (en) 1996-12-06 2004-03-16 Nanogen, Inc. Systems and devices for photoelectrophoretic transport and hybridization of oligonucleotides
CA2276462C (en) * 1996-12-31 2007-06-12 Genometrix Incorporated Multiplexed molecular analysis system apparatus and method
RU2121507C1 (en) * 1997-02-18 1998-11-10 Мавзютов Айрат Радикович Method of determination of thermostable enterotoxin gene in examples of enterobacteriaceae family
US6534273B2 (en) 1997-05-02 2003-03-18 Gen-Probe Incorporated Two-step hybridization and capture of a polynucleotide
WO1998050583A1 (en) 1997-05-02 1998-11-12 Gen-Probe Incorporated Two-step hybridization and capture of a polynucleotide
DE19741715A1 (en) * 1997-09-22 1999-03-25 Hoechst Ag New pentopyranosyl nucleoside compounds
AU746061B2 (en) * 1997-12-12 2002-04-11 Qiagen Gaithersburg, Inc. Assessment of human papilloma virus-related disease
US6458533B1 (en) 1997-12-19 2002-10-01 High Throughput Genomics, Inc. High throughput assay system for monitoring ESTs
US20100105572A1 (en) * 1997-12-19 2010-04-29 Kris Richard M High throughput assay system
US20030039967A1 (en) * 1997-12-19 2003-02-27 Kris Richard M. High throughput assay system using mass spectrometry
US20030096232A1 (en) * 1997-12-19 2003-05-22 Kris Richard M. High throughput assay system
US6232066B1 (en) 1997-12-19 2001-05-15 Neogen, Inc. High throughput assay system
US6238869B1 (en) 1997-12-19 2001-05-29 High Throughput Genomics, Inc. High throughput assay system
EP2156891A3 (en) 1998-05-01 2010-06-02 Gen-Probe Incorporated System and method for incubating the contents of a reaction receptacle
DE19824900B4 (en) 1998-06-04 2006-05-04 Roche Diagnostics Gmbh DNA detection via a strand-annealing complex
EP1988165A1 (en) 1999-03-31 2008-11-05 The University of North Carolina at Chapel Hill Isolated DNA encoding cullin regulator ROC1, isolated proteins encoded by the same, and methods utilizing the same
US6235479B1 (en) 1999-04-13 2001-05-22 Bio Merieux, Inc. Methods and devices for performing analysis of a nucleic acid sample
US7101989B1 (en) 1999-07-09 2006-09-05 University Of North Carolina At Chapel Hill DsrA protein and polynucleotides encoding the same
FR2803913B1 (en) * 2000-01-13 2002-08-16 Pasteur Sanofi Diagnostics METHOD OF IMMOBILIZING AFFIN (A) REAGENT (S) ON A HYDROPHOBIC SOLID PHASE
US7582420B2 (en) 2001-07-12 2009-09-01 Illumina, Inc. Multiplex nucleic acid reactions
US7955794B2 (en) 2000-09-21 2011-06-07 Illumina, Inc. Multiplex nucleic acid reactions
US8076063B2 (en) * 2000-02-07 2011-12-13 Illumina, Inc. Multiplexed methylation detection methods
DE60136166D1 (en) * 2000-02-07 2008-11-27 Illumina Inc NUCLEIC ACID PROOF METHOD WITH UNIVERSAL PRIMING
US20050214825A1 (en) * 2000-02-07 2005-09-29 John Stuelpnagel Multiplex sample analysis on universal arrays
US20020051981A1 (en) * 2000-03-08 2002-05-02 Robert Getts Methods for assay and detection on a microarray
AU3460600A (en) * 2000-03-16 2001-09-24 Bionex, Inc. Method for detecting mutation of nucleic acid
US7439016B1 (en) * 2000-06-15 2008-10-21 Digene Corporation Detection of nucleic acids by type-specific hybrid capture method
US7601497B2 (en) * 2000-06-15 2009-10-13 Qiagen Gaithersburg, Inc. Detection of nucleic acids by target-specific hybrid capture method
US20040185464A1 (en) * 2000-09-15 2004-09-23 Kris Richard M. High throughput assay system
US20020169562A1 (en) * 2001-01-29 2002-11-14 Gregory Stephanopoulos Defining biological states and related genes, proteins and patterns
AU2002327236A1 (en) 2001-07-12 2003-01-29 Illumina, Inc. Multiplex nucleic acid reactions
US6893822B2 (en) 2001-07-19 2005-05-17 Nanogen Recognomics Gmbh Enzymatic modification of a nucleic acid-synthetic binding unit conjugate
US20050147984A1 (en) * 2001-08-31 2005-07-07 Clondiag Chip Technologies Gmbh Interaction detection on several probe arrays
US6696254B2 (en) * 2001-11-21 2004-02-24 Kimberly-Clark Worldwide, Inc. Detection and identification of enteric bacteria
US7041811B2 (en) * 2001-12-19 2006-05-09 Dr. Chip Biotechnology, Inc. Method for detecting Escherichia coli
US20030175709A1 (en) * 2001-12-20 2003-09-18 Murphy George L. Method and system for depleting rRNA populations
US7579147B2 (en) * 2002-05-07 2009-08-25 Wake Forest University Health Sciences Mutations in the macrophage scavenger receptor 1 gene alter risk of prostate cancer, asthma, and cardiovascular disease
ES2594333T3 (en) * 2002-05-17 2016-12-19 Becton, Dickinson And Company Automated system to isolate, amplify and detect a white nucleic acid sequence
US20030219755A1 (en) * 2002-05-24 2003-11-27 Nanibhushan Dattagupta Compositions and methods for performing hybridization assays using target enhanced signal amplification (TESA)
US7601493B2 (en) * 2002-07-26 2009-10-13 Nanogen, Inc. Methods and apparatus for screening and detecting multiple genetic mutations
US20040259105A1 (en) * 2002-10-03 2004-12-23 Jian-Bing Fan Multiplex nucleic acid analysis using archived or fixed samples
WO2004041192A2 (en) * 2002-10-31 2004-05-21 Pfizer Products, Inc. Panels of molecular targets differentially expressed during cd8+ t-cell priming
AU2003302472B2 (en) * 2002-11-22 2010-10-21 The Johns Hopkins University Target for therapy of cognitive impairment
ATE479775T1 (en) * 2002-11-26 2010-09-15 Univ Maryland Biotechnology HIGHLY SENSITIVE ASSAY FOR PATHOGENE DETECTION USING METAL ENHANCED FLUORESCENCE
US20040235019A1 (en) * 2003-03-06 2004-11-25 Agouron Pharmaceuticals, Inc. Diagnostics and therapeutics for the gene expression signature of PPAR-gamma receptor ligand
CA2525413C (en) 2003-05-19 2010-08-17 Gen-Probe Incorporated Compositions, methods and kits for determining the presence of trichomonas vaginalis in a test sample
CA2545917C (en) 2003-11-14 2014-07-29 Duke University Methods of detecting charcot-marie tooth disease type 2a
GB0411081D0 (en) * 2004-05-18 2004-06-23 Glaxo Group Ltd Novel apparatus
WO2006007567A2 (en) 2004-07-01 2006-01-19 Gen-Probe Incorporated Methods and compositions to detect nucleic acids in a biological sample
US7662562B2 (en) * 2004-08-10 2010-02-16 Becton, Dickinson And Company Method for rapid identification of microorganisms
US7828954B2 (en) * 2004-09-21 2010-11-09 Gamida For Life B.V. Electrode based patterning of thin film self-assembled nanoparticles
US7314542B2 (en) * 2004-09-23 2008-01-01 Nanogen, Inc. Methods and materials for optimization of electronic transportation and hybridization reactions
EP1921454B1 (en) 2005-03-10 2015-08-12 Gen-Probe Incorporated Systems and methods to perform assays for detecting or quantifying analytes
US7932081B2 (en) 2005-03-10 2011-04-26 Gen-Probe Incorporated Signal measuring system for conducting real-time amplification assays
WO2006110314A2 (en) 2005-03-25 2006-10-19 Ambion, Inc. Methods and compositions for depleting abundant rna transcripts
ATE551433T1 (en) 2005-05-06 2012-04-15 Gen Probe Inc METHOD AND PRODUCTS FOR DETECTING NUCLEIC ACID TARGETS
WO2008060369A2 (en) 2006-09-29 2008-05-22 Translational Therapeutics, Inc. Eif4e regulon-based diagnostics
WO2007123579A2 (en) 2005-12-28 2007-11-01 Translational Therapeutics Translational dysfunction based therapeutics
US20070186298A1 (en) * 2006-01-04 2007-08-09 Blowe Charlotte D Follistatin gene as a genetic marker for reproductive and performance traits in pigs
US20080118914A1 (en) * 2006-01-04 2008-05-22 Charlotte Dawn Blowe Follistatin gene as a genetic marker for first parity litter size in pigs
EP2027293B1 (en) 2006-05-24 2014-11-19 Gen-Probe Incorporated Method of lysing mycobacterium and amplifying its nucleic acid
EP2017356B1 (en) 2006-06-06 2011-12-07 Gen-Probe Incorporated Tagged oliggonucleotides and their use in nucleic acid amplification methods
US9938641B2 (en) * 2006-12-18 2018-04-10 Fluidigm Corporation Selection of aptamers based on geometry
EP1978111B1 (en) 2007-04-02 2013-03-27 Gen-Probe Incorporated Compositions, kits and related methods for the detection and/or monitoring of Pseudomonas aeruginosa
CA2709356C (en) 2007-12-21 2019-08-06 Biomerieux Sa Detection of methicillin-resistant staphylococcus aureus
WO2009126336A1 (en) * 2008-04-11 2009-10-15 Becton, Dickinson And Company Methods of controlling the sensitivity and dynamic range of a homogeneous assay
EP2479287B1 (en) 2008-05-13 2014-07-23 Gen-Probe Incorporated Inactivatable target capture oligomers for use in the selective hybridization and capture of target nucleic acid sequences
CA2723917A1 (en) 2008-05-30 2009-12-30 Gen-Probe Incorporated Compositions, kits and related methods for the detection and/or monitoring of salmonella
US8815508B2 (en) 2008-08-12 2014-08-26 Zinfandel Pharmaceuticals, Inc. Method of identifying disease risk factors
TWI419974B (en) * 2008-10-27 2013-12-21 Qiagen Gaithersburg Inc Fast results hybrid capture assay on an automated platform
US8399222B2 (en) * 2008-11-25 2013-03-19 Gen-Probe Incorporated Compositions and methods for detecting small RNAs, and uses thereof
EP2389449B1 (en) 2008-12-30 2015-02-18 Gen-Probe Incorporated Compositions, kits and related methods for the detection and/or monitoring of listeria
US20100216147A1 (en) * 2009-01-28 2010-08-26 Qiagen Gaithersburg, Inc. Sequence-specific large volume sample preparation method and assay
AU2010242867B2 (en) * 2009-05-01 2016-05-12 Qiagen Gaithersburg, Inc. A non-target amplification method for detection of RNA splice-forms in a sample
CN105618264B (en) 2009-05-15 2021-04-06 简·探针公司 Method and apparatus for implementing automatic movement of a magnet in an instrument performing a magnetic separation procedure
EP2473624B1 (en) 2009-08-31 2019-05-01 Gen-Probe Incorporated Dengue virus assay
US9410146B2 (en) 2009-09-14 2016-08-09 Qiagen Gaithersburg Inc. Compositions and methods for recovery of nucleic acids or proteins from tissue samples fixed in cytology media
CA2787958A1 (en) 2009-12-21 2011-07-14 Becton, Dickinson And Company Methods for identifying drug resistant mycobacterium
US9404160B2 (en) 2009-12-22 2016-08-02 Becton, Dickinson And Company Methods for the detection of microorganisms
US8790879B2 (en) 2010-01-22 2014-07-29 Gen-Probe Incorporated Probes for detecting the presence of Trichomonas vaginalis in a sample
US9689047B2 (en) 2010-01-29 2017-06-27 Qiagen Gaithersburg Inc. Methods and compositions for sequence-specific purification and multiplex analysis of nucleic acids
BR112012018545A2 (en) 2010-01-29 2016-05-03 Qiagen Gaithersburg Inc method of determining and confirming the presence of an hpv in a sample
WO2011143291A1 (en) 2010-05-11 2011-11-17 Dow Agrosciences Llc Spnk strains
CA2799200A1 (en) 2010-05-19 2011-11-24 Qiagen Gaithersburg, Inc. Methods and compositions for sequence-specific purification and multiplex analysis of nucleic acids
CA2799205A1 (en) 2010-05-25 2011-12-01 Qiagen Gaithersburg, Inc. Fast results hybrid capture assay and associated strategically-truncated probes
EP2752668A3 (en) 2010-07-23 2014-10-15 Beckman Coulter, Inc. System Or Method Of Including Analytical Units
EP2678442B1 (en) 2011-02-24 2019-01-16 QIAGEN Gaithersburg, Inc. Materials and methods for detection of hpv nucleic acid
EP2520653B1 (en) 2011-05-03 2017-03-29 Dow AgroSciences LLC Integration of genes into the chromosome of saccharopolyspora spinosa
EP3225698B1 (en) 2011-09-06 2019-07-31 Gen-Probe Incorporated Closed nucleic acid structures
DE102011114984B3 (en) * 2011-09-28 2012-11-22 Universität Rostock Sequence-specific analysis of nucleic acids
EP2776846B1 (en) 2011-11-07 2019-08-21 Beckman Coulter, Inc. Aliquotter system and workflow
CN103975245A (en) 2011-11-07 2014-08-06 贝克曼考尔特公司 Magnetic damping for specimen transport system
KR20140092378A (en) 2011-11-07 2014-07-23 베크만 컬터, 인코포레이티드 System and method for processing samples
WO2013070754A1 (en) 2011-11-07 2013-05-16 Beckman Coulter, Inc. Robotic arm
EP2776843B1 (en) 2011-11-07 2019-03-27 Beckman Coulter, Inc. Centrifuge system and workflow
BR112014011043A2 (en) 2011-11-07 2017-06-13 Beckman Coulter Inc specimen container detection
US9394573B2 (en) 2011-12-23 2016-07-19 Biomerieux S.A. Detection of mecA variant strains of methicillin-resistant Staphylococcus aureus
US9631195B2 (en) 2011-12-28 2017-04-25 Dow Agrosciences Llc Identification and characterization of the spinactin biosysnthesis gene cluster from spinosyn producing saccharopolyspora spinosa
EP2843047B1 (en) 2012-02-27 2019-10-30 Toray Industries, Inc. Nucleic acid detection method
WO2013181553A2 (en) 2012-06-01 2013-12-05 Akron Biotech Detection of mycoplasma in cell cultures and cell culture derived biologicals
WO2014006025A2 (en) 2012-07-02 2014-01-09 INSERM (Institut National de la Santé et de la Recherche Médicale) Marker of pathogenicity in salmonella
CA2883499C (en) 2012-08-31 2020-07-14 Toray Industries, Inc. Method for detecting target nucleic acid
US10427162B2 (en) 2016-12-21 2019-10-01 Quandx Inc. Systems and methods for molecular diagnostics
CA3108105A1 (en) 2018-08-08 2020-02-13 Gen-Probe Incorporated Compositions, methods and kits for detecting mycoplasma genitalium
AU2020210753A1 (en) 2019-01-25 2021-09-02 Gen-Probe Incorporated Detection of drug-resistant mycoplasma genitalium
US20220298548A1 (en) 2019-08-23 2022-09-22 Gen-Probe Incorporated Compositions, methods and kits for detecting treponema pallidum
CA3188657A1 (en) 2020-07-17 2022-01-20 Gen-Probe Incorporated Detection of macrolide-resistant mycoplasma genitalium
WO2024099985A1 (en) 2022-11-10 2024-05-16 Bayer Aktiengesellschaft Targeted crop protection product application based on genetic profiles

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3896217A (en) * 1973-03-19 1975-07-22 Summa Corp Method and apparatus for radioimmunoassay with regeneration of immunoadsorbent
US3930956A (en) * 1973-10-29 1976-01-06 The Regents Of The University Of Michigan Method for the genetic detection of microorganisms
SU649751A1 (en) * 1977-06-14 1979-02-28 Московский Ордена Ленина И Ордена Трудового Красного Знамени Государственный Университет Им.М.В.Ломоносова Method of identification of microorganisms
US4139346A (en) * 1977-11-28 1979-02-13 Enzo Bio Chem Incorporated Nucleic acid and protein binding paper
FR2422956A1 (en) * 1978-04-13 1979-11-09 Pasteur Institut METHOD OF DETECTION AND CHARACTERIZATION OF A NUCLEIC ACID OR OF A SEQUENCE OF THE SAME, AND ENZYMATIC REAGENT FOR THE IMPLEMENTATION OF THIS PROCESS
FR2444713A1 (en) * 1978-12-18 1980-07-18 Pasteur Institut PROCESS FOR PRODUCING DNA COMPRISING THE GENOME OF HEPATITIS B VIRUS AND VECTOR COMPRISING SAME
US4302204A (en) * 1979-07-02 1981-11-24 The Board Of Trustees Of Leland Stanford Junior University Transfer and detection of nucleic acids
US4359535A (en) * 1979-10-01 1982-11-16 George Pieczenik Autonomously replicating DNA containing inserted DNA sequences
US4358535A (en) * 1980-12-08 1982-11-09 Board Of Regents Of The University Of Washington Specific DNA probes in diagnostic microbiology
US4446237A (en) * 1981-03-27 1984-05-01 Life Technologies, Inc. Method for detection of a suspect viral deoxyribonucleic acid in an acellular biological fluid
EP0062286A1 (en) * 1981-03-31 1982-10-13 Albert Einstein College Of Medicine Of Yeshiva University Diagnostic test for hepatitis B virus
CA1219824A (en) * 1981-04-17 1987-03-31 David C. Ward Modified nucleotides and methods of preparing and using same
JPS5840099A (en) * 1981-07-17 1983-03-08 アモコ・コ−ポレ−ション Hydrid diagnosis of light projecting polynucleotide
FI63596C (en) * 1981-10-16 1983-07-11 Orion Yhtymae Oy MICROBIA DIAGNOSIS FOERFARANDE SOM GRUNDAR SIG PAO SKIKTSHYBRIDISERING AV NUCLEINSYROR OCH VID FOERFARANDET ANVAENDA KOMBINATIONER AV REAGENSER

Also Published As

Publication number Publication date
EP0079139B1 (en) 1988-01-07
JPH0632637B2 (en) 1994-05-02
DK275183D0 (en) 1983-06-15
SU1386031A3 (en) 1988-03-30
CA1192120A (en) 1985-08-20
ATE31735T1 (en) 1988-01-15
DK275183A (en) 1983-06-15
RO86356A (en) 1985-03-15
DE3277917D1 (en) 1988-02-11
RO86356B (en) 1985-04-01
US4563419A (en) 1986-01-07
US4486539A (en) 1984-12-04
FI63596B (en) 1983-03-31
DK173744B1 (en) 2001-09-03
EP0079139A1 (en) 1983-05-18
AU8957582A (en) 1983-05-05
DE79139T1 (en) 1983-11-24
WO1983001459A1 (en) 1983-04-28
JPS58501703A (en) 1983-10-13
AU548854B2 (en) 1986-01-02
HU196242B (en) 1988-10-28
EP0098267A1 (en) 1984-01-18
JPH0632637B1 (en) 1994-05-02

Similar Documents

Publication Publication Date Title
FI63596C (en) MICROBIA DIAGNOSIS FOERFARANDE SOM GRUNDAR SIG PAO SKIKTSHYBRIDISERING AV NUCLEINSYROR OCH VID FOERFARANDET ANVAENDA KOMBINATIONER AV REAGENSER
EP0133671B1 (en) Detection of bacteria by nucleic acid hybridization, labeled probes and test kit therefore
US4358535A (en) Specific DNA probes in diagnostic microbiology
JP2798499B2 (en) Infectious disease diagnostic probe
US5614388A (en) PCR primers for detection of legionella species and methods for controlling visual intensity in hybridization assays
JP2607496B2 (en) Campylobacter detection probe
EP0133288A2 (en) Bacterial detection by nucleic acid hybridization, labeled probes and test kit therefore
US5942394A (en) Detection of protozoan parasites
CN110923362B (en) Colloidal gold chromatography kit for simultaneously detecting herpes simplex virus type I/II and application thereof
EP0484385A4 (en) Quantification of bacteria using a nucleic acid hybridization assay
CN114790490A (en) Molecular marker capable of distinguishing Brucella melitensis and detection method
JP2000511058A (en) Compositions and methods for detecting Mycobacterium Kansasii
JPH03206899A (en) Nucleic acid probe and method for use in detection of cryptocox neoholmance
JPH10508499A (en) Nucleotide sequences that specifically hybridize to Campylobacter genomic nucleic acid sequences
JPH07184697A (en) Oligonucleotide to detect enterobacteriaceae bacteria
US5348857A (en) Probes and method for identifying species and biovars of brucella
CN116334255B (en) A novel nucleic acid detection kit for Salmonella and its non-diagnostic detection method
JP2004290171A (en) Molecular biological identification technique of microorganism
NO163699B (en) PROCEDURE AND REAGENT COMBINATION FOR DIAGNOSIS OF MICROORGANISMS.
CN110923347B (en) Ureaplasma urealyticum nucleic acid detection colloidal gold chromatography kit and application thereof
Begaud et al. Detection of enterotoxigenic Escherichia coli in faecal specimens by acetylaminofluorene-labelled DNA probes
CN116064943A (en) Probe, primer set and kit for detecting cat parvovirus and bordetella bronchiseptica and application
WO2025063721A1 (en) Composition for nucleic acid purification or extraction and use thereof
CN106755423B (en) Specific sequence-based escherichia coli and shigella detection primer, kit and detection method
CN113652494A (en) Probe, primer group and kit for detecting helicobacter pylori

Legal Events

Date Code Title Description
MA Patent expired

Owner name: SANGTEC MOLECULAR DIAGNOSTICS AB